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ABSTRACT 
Laying-hens efficiently transfer nutrients from their feed to the resulting eggs, and 
nutrients from feed are distributed in many organs and tissues for various uses.  Annatto 
is the only known source of tocotrienols (T3s) (gamma-T3 ~10% and delta-T3 ~90%) 
without alpha-tocopherol present.  The T3s have many health benefits including lowering 
cholesterol.  The objective of this research was to study the effect of alpha-tocopherol on 
the transfer of T3s to eggs and various organs and tissues in the body of the laying-hen.  
To do so, laying-hens were fed treatment diets for 7 weeks supplemented with annatto 
T3s in the presence and absence of alpha-tocopherol.  The diet regimens were a control 
diet with not supplementation and three diets with 2000 ppm annatto extract and added 
alpha-tocopherol at 200 and 1000 ppm.     
No significant differences were found in egg production or egg yolk properties 
(moisture content of moisture, lipid, phospholipids, fatty acids, or cholesterol).  
Significant differences (p<0.05) were found in feed intake, yolk viscosity, sensory yolk 
flavor and color, and transfer efficiency of tocopherols and T3s to the egg yolks.   
Alpha-tocopherol was transferred more efficiently (21.19-49.17%) than gamma-
T3 (0.50-0.96%) or delta-T3 (0.74-0.93%) to the egg yolks.  Addition of 1000 ppm of 
alpha-tocopherol decreased the transfer of gamma-T3 (by 23.76%) but it did not impact 
the transfer of delta-T3 to the egg yolk.  The addition of annatto T3s did not significantly 
impact the cholesterol content of the laid eggs.   
A total of 18 organs or tissues (skin, fat pad, liver and gall bladder, heart, oviduct, 
forming yolk, laid yolk, lungs, spleen, kidney, pancreas, gizzard, digestive tract, brain, 
thigh, breast, manure, and blood) were collected after 7 weeks of feeding the diets.  
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Tissue weights, moisture content (except for manure), lipid, alpha-tocopherol, gamma-
T3, delta-T3, cholesterol, and fatty acid composition of extracted lipids in the collected 
organs and tissues (except for blood) were determined.   
Tissue weights, moisture content, and lipid content did not change significantly 
with feed supplementation across treatments, except that the liver became heavier with 
increased supplementation.  Minimal changes were found in the fatty acid composition, 
except in the fat pad, oviduct, brain, and manure.   
Overall, the main organs that accumulated the supplemented forms of vitamin E 
were fat pad, liver and gall bladder, oviduct, forming yolks, laid yolks, kidney, brain, 
thigh, and breast.  Much of annatto supplement (gamma-T3 and delta-T3) was detected in 
the manure (>90%), indicating that most was excreted and not used by the hen. In some 
tissues (brain and oviduct) a significant increase in polyunsaturated fatty acids was seen 
with increased supplementation.   Alpha-tocopherol impacted the transfer of gamma-T3 
to the forming and laid yolks, but did not impact delta-T3 transfer.  No significant 
differences were found in the cholesterol in the liver, kidney, laid yolks, breast meat, 
oviduct, or thigh meat, except for cholesterol reduction in the heart based on as-is tissue 
weight.  Blood samples showed large variation among individual hens with no significant 
differences in total cholesterol, HDL, or total triacylglycerols.   
The results indicate that supplementing hen-laying feed with annatto T3s and 
alpha-tocopherol can alter the vitamin E profile and its distribution among the laid eggs 
and laying-hen organ and tissues (especially in the liver and egg yolks).  Therefore it is 
possible to enhance the nutritional profile of the egg to further benefit the consumers and 
to increase oxidative stability of various organs and tissues.    
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CHAPTER 1 
GENERAL INTRODUCTION 
Egg Nutrition 
 Eggs are the gold standard for protein (complete amino acid profile), source for 
many micronutrients, including choline, lutein, zeaxanthin, and vitamin D in the diet 
(Egg Nutrition Center, 2014) , and low in calories (70 Calories per large egg) and cost.  
Eggs are the most affordable complete protein (Iowa Egg Council, 2014).  Eggs are 
believed to be part of a healthy and well-balanced diet (American Egg Board, 2011).  
Moreover, eggs possess many functional properties that are useful to many industries, 
such as medical, pharmaceutical, cosmetic, nutraceutical, and biotechnological (Anton et 
al., 2007 and Aro et al., 2009). 
Laying-hens are very efficient at transferring nutrients from their feed to the 
resulting eggs (fat soluble nutrients transfer to egg yolk). This fact provides a method to 
alter the nutritional composition of eggs (Walker et al., 2012 and Yao et al., 2013) as a 
means for human nutrition.  Along with supplementation, genetics, environment, and age 
also play roles in affecting the egg composition (Frediksson et al., 2006) and quality 
(Koelkebeck, 2014).   
Eggs consist of a yolk, albumen (white), and shell.  The yolk makes up 
approximately one third (36%) by weight of the egg.  The egg yolk is approximately 50-
52% solids depending upon breed, age, storage conditions, and storage time (Anton et al., 
2007).  The majority of the dry solids in the egg yolk are lipids (62.5%) and proteins 
(33%), with minor carbohydrates (1-2%) and minerals (3-4%).   
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The lipids are composed of triglycerides (62%), phospholipids (33%), cholesterol 
(<5%), and carotenoids (<1%) (Anton et al., 2007).  The fatty acid composition, based on 
typical commercial diet, of these lipids classes are saturated fatty acids (SFA, 30-35%), 
monounsaturated fatty acids (MUFA, 40-45%), and polyunsaturated fatty acids (PUFA, 
20-25%).  Within these lipid classes, the main fatty acids are oleic acid (C18:1, 40-45%), 
palmitic acid (C16:0, 20-25%), and linoleic acid (C18:2, 15-20%) (Anton et al., 2007).  
The main phospholipids found in the egg yolk are phosphatidylcholine (PC, 76%) and 
phosphatidylethanolamne (PE, 22%).  Other minor phospholipids found in egg yolk 
include; phosphatidylinositol (PI), phosphatidylserine (PS), sphingomyelin (SM), 
cardiolipins (CL), lysoPC, and lysoPE (Anton et al., 2007).   
Changing laying-hen feed composition can lead to alteration of the composition 
of the egg.  When the composition of an egg and egg yolk is considered, it is important to 
know that both positive and negative changes can occur with different feeds or 
environmental conditions.    
Rationale for Nutrient Enrichment  
Vitamin E is a fat soluble vitamin which has eight major forms classified into two 
major groups, tocopherols and tocotrienols (T3s).  These groups differ in 3 double bonds 
(unsaturation) on the phytyl tail of the T3s (Sontag et al., 2007).  Within each of these 
groups (tocopherols and T3s), there is an alpha, beta, gamma, and delta form varying in 
the number and position of the methyl groups on the chromanol ring (Sontag et al., 2007).  
Alpha-tocopherol is the most bioavailable form due to the presence of an alpha-
tocopherol transfer protein in the liver.  This protein has higher affinity for the alpha-
tocopherol form of vitamin E, causing biodiscrimination against the other forms of 
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vitamin E (Traber et al., 1999).   Alpha-tocopherol being the most bioavailable could 
dominate the absorption, causing poor absorption of the T3s.      
T3s have been shown to have many health benefits not possessed by the 
tocopherol counterparts.  One significant benefit is lowering cholesterol by down-
regulating a key hepatic enzyme in cholesterol synthesis (3-hydroxy-menthyglutaryl 
coenzyme A reductase) (Qureshi et al., 1986; Pearce et al., 1992; Parker et al., 1993; 
Qureshi et al., 2000; Qureshi et al., 2001; Qureshi et al., 2001; Yu et al., 2006; and Yang 
et al., 2013).  Yu et al. (2006) showed that supplementation of 50-2000 ppm of delta and 
gamma T3s to 5-week-old female chickens caused decreases in total serum cholesterol by 
32% and decreases of LDL levels by 66%, with minimal changes to HDL cholesterol.   
 Vitamin E has been supplemented to laying-hen feed in many studies; Walker et 
al. (2012) showed that fat soluble nutrients (like vitamin E) reach a steady state after 8-10 
days of feeding.  Previous work has studied how T3s are transferred to eggs from feed 
(Walker et al., 2012 and Walde et al., 2013), but none examined the efficiency of transfer 
without alpha-tocopherol present.  In the previous studies mentioned, the sources of 
tocopherols and T3s used (palm and barley) have alpha-tocopherol naturally present, 
making it impossible to observe T3 transfer without the influence of alpha-tocopherol.  
Ikeda et al. (2003) showed that alpha-tocopherol at certain levels blocked selected T3 
forms (alpha-T3) but not others (gamma-T3), thus alpha-tocopherol must be at the proper 
concentration to optimize transfer of T3s.  Having alpha-tocopherol supplemented at the 
correct level will allow the benefit of added alpha-tocopherol but not to an extent that it 
will attenuate the T3s transfer.  Alpha-tocopherol being present at certain levels has been 
shown to block or decrease the benefits of T3s (Qureshi et al, 1996).   
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 Annatto is the only known natural source of T3s (delta ~90% and gamma ~10%) 
without alpha-tocopherol naturally present
 
(Frega et al., 1998).  Using annatto extract 
makes it possible to determine T3 transfer to the egg yolk both in the presence and 
absence of alpha-tocopherol.  Walde et al. (2013) showed that the addition of barley or 
palm to laying-hen feed decreased egg yolk cholesterol by 4 or 6%, respectively.  
However, the presence of alpha-tocopherol in the source of T3s this may have hindered 
T3 transfer.  Using annatto will allow for T3s to be exposed to the biological system 
without alpha-tocopherol’s interference or influence.  This may possibly increase 
bioaccumulation, and consequently it may lower cholesterol further in the resulting eggs. 
 Egg yolk is composed of many classes of lipids, but the most notorious lipid is 
cholesterol.  Historically, eggs were thought to be unhealthy due to high concentration of 
cholesterol in the yolk.  High cholesterol in the human body and blood is associated with 
higher risk of cardiovascular disease.  However, as more research has been done, this 
opinion has shifted to suggest dietary cholesterol is a small part in heart health (Kantor et 
al., 2012).  Nonetheless, the concern of cholesterol has caused many consumers to avoid 
consuming the highly nutritious eggs routinely.  Reducing the amount of cholesterol in 
eggs (currently 186 mg per large egg according to USDA, 2014), may help encourage 
more egg consumption.   
 T3s are unique compounds that have many health benefits.  We wanted to 
determine the effects of supplementing laying-hen feed with annatto T3s and alpha-
tocopherol on T3s transfer to egg yolk, the effect of alpha-tocopherol on transfer of T3s 
to egg yolk, and the impact of T3s on cholesterol content in egg yolk.     
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Rationale for Distribution Determination 
 As stated above, there is biodiscrimination in the uptake of the various forms of 
vitamin E.  Many studies (Nockels et al., 1976; Tengerdy et al., 1977; Surai et al., 2000; 
and Tres et al., 2012) have shown vitamin E distribution in a select number of organs 
(liver especially).  But a study examining all laying-hen organs and characterizing other 
components (moisture, lipid, fatty acid, and cholesterol) is lacking in literature.   
 To obtain a complete understanding of how the alpha-tocopherol, gamma-T3, and 
delta-T3 from the supplements were distributed throughout the body of the laying-hens, 
18 organ/tissue and by-product samples (skin, fat pad, liver and gall bladder, heart, 
oviduct, forming yolk, laid yolk, lungs, spleen, kidney, pancreas, gizzard, digestive tract, 
brain, thigh, breast, manure, and blood) were collected and examined.  The composition 
obtained will help better understand the transfer and impact of the nutrients supplemented 
in the biological system.   
 If the vitamin E supplement can lead to increased concentration in certain tissues, 
this could result in a healthier laying-hen and higher quality products (i.e. eggs and meat).  
Higher levels of T3s in the tissues and food products derived from the laying-hens could 
improve oxidative stability as well, as alpha-tocopherol has been shown to reduce 
oxidation in chicken meat products (Brenes et al., 2008).         
Thesis Organization 
This thesis contains a general introduction, literature review, two manuscripts as prepared 
for submission to two different journals, and general conclusions.   
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CHAPTER 2 
LITERATURE REVIEW 
Vitamin E: Tocopherols and Tocotrienols 
 Vitamin E is a fat soluble vitamin, and is grouped into tocopherols and 
tocotrienols (T3s).  The major difference between these two classes (tocopherols and 
T3s) is the three double bonds (unsaturation) in the hydrophobic tail (phytyl tail) at the 
3’, 7’, and 11’ positions in the T3s.  These unsaturations cause the structure of T3s to be 
more rigid (lack ability to spin and move) giving unique properties not had by the 
tocopherol counterparts.  Within tocopherol and T3 classes there are four forms alpha, 
beta, gamma, and delta, differing in the number and position of methyl groups on the 
chroman ring (Figure 1).  Of these eight forms, alpha-tocopherol with three methyl 
groups on the chroman ring is the most bioavailable.   
 
Form R1 R2 R3 
Alpha –CH3 –CH3 –CH3 
Beta –CH3 –H –CH3 
Gamma –H –CH3 –CH3 
Delta –H –H –CH3 
Tocopherols = no unsaturation 
Tocotrienols (T3s) = unsaturation/double bonds at 3’, 7’, and 11’ 
 
Figure 1. Structure of various vitamin E forms (tocopherols and tocotrienols) modified 
from Sontag et al. (2007) 
 
Vitamin E is an essential nutrient and cannot be made (or interconverted) by the 
human body, thus must be consumed in the diet (Gropper et al., 2013).  Vitamin E (alpha-
tocopherol) status is believed to be good in the United States with sufficient intake of 
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vitamin E (National Academy of Science, 2000).  Factors to consider that may impact the 
accuracy of this conclusion are use of supplements and underreporting of fat in diet 
(National Academy of Science, 2000).  There may be minimal cases of deficiency with 
most cases thought to be caused by genetic defects impacting vitamin E uptake and 
utilization by the body (Brigelius-Flohe et al., 1999).  The recommended daily allowance 
(RDA) of vitamin E for men and women is 15 mg alpha-tocopherol per day (National 
Academy of Science, 2000).  The RDA has no consideration of the other forms of 
vitamin E due to high bioactivity of alpha-tocopherol (National Academy of Science, 
2000).   
 The main function of vitamin E in a biological system is preventing oxidation, 
especially of lipids.  It prevents oxidation by breaking the chain of radical reactions by 
quenching and scavenging free radicals.  Terminating lipid oxidation reduces oxidative 
stress in a system (National Academy of Science, 2000).  Oxidative stress is currently the 
leading theory for aging and many other chronic diseases (Shokolenko et al., 2014).    
Antioxidants, like vitamin E, are needed in the human body and other biological 
systems.  This is evident because when vitamin E is deficient symptoms are wide-spread 
throughout the body.  Symptoms of vitamin E deficiency may include; muscle pain, 
weakness, hemolytic anemia, degenerative neuropathy, fragile membranes, and others 
(Gropper et al., 2013).   
Other studies have shown that vitamin E has various roles in improving many 
chronic diseases.  Some examples include; cardiovascular disease (Stampfer et al., 1993; 
Stephens et al., 1996; National Academy of Science, 2000; and Gropper et al., 2013), 
11 
 
 
 
cancer (Seifried et al., 2007 and Gropper et al., 2013), and eye health (Mares-Paerlman et 
al., 2000; Jacques et al., 2005; and Gropper et al., 2013). 
Increased intake of vitamin E has helped to prevent the oxidation of LDLs, 
cholesterol, and other lipid components in the body and blood, thus reducing the risks of 
cardiovascular disease.  The reduced chance of cancer is related to the ability of vitamin E to 
remove free-radicals that could damage the gene or genetic regulation leading to cancer.  
Vitamin E may play a role in reducing risk of diabetes (aiding in plasma membrane in 
glucose uptake), Alzheimer’s disease (reduce oxidative stress and possibly reduce protein 
aggregates), and other diseases (Gropper et al., 2013).         
Interest has grown in T3s because of the many unique health benefits they 
possess.  Many T3 benefits are not had or are not as effective in tocopherol counterparts.  
These benefits include higher potency antioxidant, anti-tumor, lowering cardiovascular 
disease and hypertension, and neuroprotection (Yang et al., 2013 and Qureshi et al., 
2000).  A significant benefit of T3s is lowering cholesterol by down-regulating the 
hepatic enzyme 3-hydroxy-menthyglutaryl coenzyme A reductase, that is the rate limiting 
enzyme in cholesterol synthesis (Qureshi et al., 1986; Pearch et al., 1992; Parker et al., 
1993; Qureshi et al., 2000; Qureshi et al., 2001; Qureshi et al., 2001; Yu et al., 2006; 
Yang et al., 2013).  Walde et al. (2013) showed a 4% to 6% reduction of cholesterol in 
laid eggs when fed palm and barley, respectively.     
Qureshi et al. (1986) first discovered that the structure of the cholesterol lowering 
compound in barley was a T3 (alpha-T3).  In his later work, he continued to build 
evidence of the ability of the T3s to lower cholesterol by impacting its synthesis.  Qureshi 
et al. (1996) fed 6-week-old female chickens amaranth which showed reductions in the 
total serum cholesterol of 10-30% and LDL cholesterol of 7-70%, minimal effects to 
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HDL cholesterol, higher activity of 10-18% of 7-alpha-hydroxylase that is responsible for 
converting cholesterol to bile salts, and lower activity of approximately 9% of the rate 
limiting enzyme in cholesterol synthesis (3-hydroxy-menthyglutaryl coenzyme A 
reductase).  In this work, the authors suggested with such drastic improvements in 
cholesterol profiles, that another substance may be present that may enhance or mimic the 
effects of T3s.  Qureshi et al. (2001) also showed that T3s from rice bran suppressed 
cholesterol synthesis and improved blood lipid chemistry in swine by lowering total 
serum cholesterol by 32-38% and LDL cholesterol by 35-43%.  Yu et al. (2006) showed 
that supplementing 50-2000 ppm in feed of delta and gamma T3s caused decreases in 
total serum cholesterol (32%), LDL levels (66%), and TAGs, with minimal changes to 
HDL cholesterol in 5-week-old female chickens.  Overall, many of the papers published 
in this area have used younger animal models.      
Sen et al. (2006) and Yang et al. (2013) reviewed many health benefits provided 
by T3s in detail, analyzed data from many studies to show a wide-spread action and 
benefit of the T3s throughout the biological system.  As more is discovered about T3s 
and the more roles are found, there is a need to efficiently deliver the T3s to the 
biological systems.    
Absorption and Transport of Vitamin E 
 Many factors can affect bioavailability of vitamin E to a biological system.  Food 
matrix, formulation, and processing can affect how vitamin E is absorbed and transported 
within the body or biological system (Reboul et al., 2006).  Alpha-tocopherol is the most 
bioavailable form of vitamin E due to the presence of an alpha-tocopherol transfer protein 
in the liver that has higher affinity and selectivity for alpha-tocopherol.  This affinity 
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arises from structural differences in the forms of vitamin E (Figure 1).  Selectivity and 
recognition by the alpha-tocopherol transfer protein relies on three methyl groups on the 
chromanol ring (especially the methyl at C5), hydroxyl group on the chromanol ring, and 
phytyl chain structure and orientation (Traber et al., 1999).  The methyl groups also 
impact the special abilities of T3s (Sontag et al., 2007), with some T3 forms being more 
functional.  This preference causes biodiscrimination against non-alpha-tocopherol forms 
of vitamin E (Traber et al., 1999).   
 In humans, vitamin E from the diet is first absorbed as a micelle from the small 
intestine and packaged into a chylomicron with other hydrophobic/lipid constituents from 
the diet.  Vitamin E within the chylomicron is then transported to the liver by the lymph 
system.  In laying-hens the uptake of lipid substances from the diet occurs slightly 
different.  Lipid substances, including vitamin E, are delivered to liver by portomicrons 
(lipid rich proteins released by intestine) through the portal vein (Surai et al., 2001), due 
to the lack of a lymph system.  In the liver, the alpha-tocopherol transfer protein will 
selectively and preferentially bind to alpha-tocopherol and be further secreted into the 
circulation of the body, while other forms are mostly excreted due to longer times in the 
liver (National Academy of Sciences, 2000).  
 The alpha-tocopherol transfer protein was thought to be expressed in the liver 
exclusively (Yoshida et al., 1992; Sato et al., 1993; and Arita et al., 1995), but Hosomi et 
al. (1998) detected this protein in the brain, spleen, lungs, and kidney of rats.  This may 
signify that other tissues of the body have a preference for certain forms of vitamin E as 
well.  Even though alpha-tocopherol is the most bioavailable form, the other forms of 
vitamin E are also important in the body, even at low concentrations.  
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  T3s are thought to be more efficient than tocopherols, with less T3s needed for 
the same function of alpha-tocopherol.  For this reason, less T3s may be needed for the 
same protection or benefit.  Alpha-tocopherol is found in the cellular membrane at one 
part for approximately every 1,000 lipid molecules (Burton et al., 1990).  It is thought that 
alpha-T3 is three times more efficient at scavenging free radicals than alpha-tocopherol 
(Lanari et al., 2004).  It was suggested that this is because T3s can be more uniform, due 
to a more rigid structure, within a cellular membrane.  T3s have been shown to have a 
larger impact on the oxidative stress measurements in exercise endurance in rats (Lee et 
al., 2009).  In this study different treatments of similar levels of T3s and alpha-tocopherol 
(25mg/kg) were compared, with the T3 diet having significantly lower oxidative stress 
and longer endurance times that was not seen in the alpha-tocopherol diet.  Even with 
poor uptake of T3s, a much lower concentration is thought to be needed for the benefits. 
Annatto Tocotrienols  
The tocopherol forms of vitamin E is reported to be found in corn, wheat, and 
soybeans, while the T3 forms are reported to be in annatto, barley, oats, palm, and rice 
bran (Aggarwal et al., 2010).  In these there are various amounts of the eight forms of 
vitamin E varying with source. With laying-hens it may be possible to supplement feed 
with the various forms of vitamin E and add eggs as a source of both tocopherols and T3s 
in the diet.    
Annatto is the only known natural source of T3s (delta ~90% and gamma ~10%), 
without alpha-tocopherol present (Frega et al, 1998).  Without the presence of alpha-
tocopherol, the transfer of the T3s to a biological system, such as laying-hen egg yolks, 
may be improved.  Annatto is naturally derived from the Bixa orellana rainforest plant 
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with high purity.  Annatto is potent in color, a bright red-orange from its carotenoids 
(bixin and norbixin) (Frega et al, 1998).   
Annatto currently is a GRAS substance and its added into a variety of foods and 
products for coloring (U.S. Food and Drug Administration, 2014).  It is specifically used 
by the food industry to give certain dairy products the characteristic yellow color (Frega 
et al, 1998).  Annatto’s high density of T3s (delta and gamma) make it have other 
applications and benefits beyond coloring.     
Cholesterol Lowering 
  Cholesterol is a polycyclic amphiphilic compound (Figure 2) that is made by 
animals, and can be in free or esterified form (cholesterol ester at the hydroxyl group)  
(American Oil Chemists’ Society, 2014).  Most cholesterol in the body is found in plasma 
membrane bilayers, and it facilitates the fluidity and organization of the structure.  
Cholesterol tends to accumulate (approximately a quarter) in the brain of a biological 
system (AOCS’, 2014).  Cholesterol is transported throughout the body in lipoproteins 
(chylomicron, VLDL, LDL, and HDL), and these are the measurements of cholesterol 
status in the body.    
  
 
Figure 2. Structure of free cholesterol 
 
  Cholesterol is a very important molecule in the body and is a precursor for bile 
salts, vitamin D, and steroid hormones.  It is also an important compound in signal 
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transduction, sperm development, embryonic development, and other functions.  
Cholesterol can be made by most animals (vertebrates mainly), while others 
(invertebrates mainly) must consume it (AOCS’, 2014).     
  Cholesterol can be made in vivo.  The synthesis starts with acetoacetyl-CoA and 
acetyl-CoA to form 3-hydroxymethyl-glutaryl-CoA.  The product is then transformed to 
mevalonate.  This step is the rate limiting step in cholesterol synthesis and it is catalyzed 
by the hepatic enzyme 3-hydroxy-menthyglutaryl coenzyme A reductase (HMG Co-A 
reductase).  This enzyme is the target of many cholesterol lowing drugs, such as statins, 
in order to lower cholesterol production.    Melvalonate is then converted to 
isopentylpyrophosphate, which is used to build a larger structure by first making farnesyl 
pyrophosphate followed by squalene.  To finally make the cholesterol structure, three 
methyl groups are removed, a double bond is reduced in the hydrocarbon tail, and the 
double bond is moved (Berg et al., 2012).   
  Once synthesized in the liver, cholesterol is transported throughout the body by 
lipoproteins (such as chylomicrons, VLDLs, LDLs, and HDLs).  Chylomicrons 
(portomicrons in laying-hens) transport cholesterol from dietary sources.  Very low 
density lipoproteins (VLDLs) are mostly fat, low density lipoproteins (LDL) are known 
as “bad cholesterol” that deposit cholesterol throughout the body, and high density 
lipoproteins (HDL) are known as “good cholesterol” that transport cholesterol from the 
body back to the liver.  LDL contributes to atherosclerosis while HDL reverses it, and 
both of these are important parameters medically.  Levels or ratios (i.e. LDL:HDL) of 
these lipoproteins are used for medical diagnostic purposes that indicate cholesterol status 
in the body (Berg et al., 2012).   
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  The body regulates how much cholesterol is produced in many ways.  For 
example, if the diet provides cholesterol, feedback inhibition will lower the activity of 
HMG Co-A reductase to lower the amount of cholesterol synthesized.  The reverse is also 
true, making dietary cholesterol a minor importance in the level of cholesterol in the body 
because if it is not in the diet, the body will make what is needed.  Overall, short term 
regulation includes feedback inhibition, and long term regulation includes making less of 
the rate limiting enzyme (HMG Co-A reductase) (Berg et al., 2012).  In some individuals, 
dietary cholesterol has a larger impact, but this is only a small percent of the population 
(Fernandez et al., 2010), making genetics a significant factor in determining if an 
individual has higher than normal level of cholesterol in the body.  Other factors also 
important in consideration of cholesterol and heart health are fat intake especially 
saturated, and other lifestyle factors (Kanter et al., 2012).   
  Cholesterol is found in products of animal origin (i.e. meat, dairy, and other 
animal products).  Eggs are characterized as the food source with the highest 
concentration of cholesterol (currently 186 mg per large egg according to USDA, 2014).  
The association of cholesterol and cardiovascular disease has made consumers shy away 
from consuming eggs on a regular basis.  Eggs are the gold standard for protein 
(complete amino acid profile), unique source for many micronutrients (including choline, 
lutein, zeaxanthin, and vitamin D, Egg Nutrition Center, 2014) in the diet, and they are 
low in calories and costs (Iowa Egg Council, 2014). Long term consumption of eggs (i.e. 
dietary cholesterol with low saturated fats) in moderation is not associated with bad heart 
health and is instead part of a healthy diet (Kanter et al., 2012 and American Egg Board, 
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2011).  One would hope that the cholesterol concern of eggs would not make people 
consume less of this nutritious food.   
Cholesterol Quantification  
The standard for quantification of cholesterol is saponification and then GC 
(AOCS method Ca 6b-53).  This method is very time and solvent intensive and can be 
cumbersome quantification.  There are many methods that are similar to this method but 
use different conditions and settings, such as the AOAC method (941.09).  In all of these 
methods, saponification is done, which exposes the sample to a harsh heated alkaline 
condition.  This condition could degrade the cholesterol, as it is reported that cholesterol 
was heat labile at 45°C in the presence of 1M KOH for 3 hours (Busch et al., 2010).  
These are conditions milder than that used in various cholesterol quantification 
procedures mentioned.  This raises the concern that current methods may create variance 
and are underestimating the cholesterol content.  In addition, cholesterol is present in two 
forms; free and esterified.  It is known that cholesterol esters take longer to hydrolyze 
during saponification than other lipid esters (Christie et al., 2010).  Eggs are reported to 
have 10-15% of the cholesterol present as esters (Bitman et al., 1980), making this an 
important consideration in quantification of cholesterol in egg yolks.  This is especially 
important with cholesterol being a hot topic for egg nutrition.  More research needs to be 
done to investigate the stability of cholesterol under the saponification conditions.  
Overall, the saponification conditions may be too harsh and degrade cholesterol but may 
also be too mild to free cholesterol esters.  Alternatively, a cholesterol kit method can be 
used. The kit is equipped with enzymes (i.e. cholesterol ester hydrolase) that will rapidly 
free cholesterol esters to ensure both ester and free forms are quantified.   
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The technique used in this study to quantify cholesterol was the kit method in 
order to quantify total cholesterol (free and esters).  Various chemical and enzymatic 
reactions occur in this kit method.  First, cholesterol esters are freed by cholesterol ester 
hydrolase.  Cholesterol oxidase will oxidize the freed cholesterol along with free 
cholesterol already present in the sample producing hydrogen peroxide.  Peroxidase then 
catalyzes a reaction between hydrogen peroxide, 3,5-dimethoxy-N-ethyl-N-(2-hydroxy-3-
sulfopropyl)-aniline sodium salt (DAOS), and 4-aminoantipyrine.  The product of this 
reaction results in a blue pigment that can be spectrophotometrically measured.  The 
absorbance of this measurement is related linearly to the concentration of cholesterol in 
the sample (Wako Diagnostics, 2014).   
Egg Formation 
Laying-hens are very efficient birds at producing eggs, laying an egg almost every 
day when in good health and housing conditions.  Approximately 100g of feed is 
consumed daily by the laying-hen and approximately a 60g egg (size is impacted by 
genetics, age, clutch order, number of eggs produced, maturity, season, temperature, 
housing, disease, and other environmental factors) is produced.   After the laying cycle 
has finished (about 23-26 hours), after only 30 minutes, the laying-hen’s reproductive 
system is again starting the cycle to lay another egg (Scanes et al., 2004).  Many 
anatomical features and steps are needed to lay an egg efficiently incorporating nutrients 
from feed.   
Fat soluble nutrients, such as vitamin E, are efficiently taken into the system as 
described previously.  The fat soluble pigment xanthophyll is reported to be transferred 
very quickly from the digestive tract to the blood stream and finally to the yolk (USDA, 
20 
 
 
 
2000).  Overall, all fat soluble nutrients (vitamin E and astaxanthin), Walker et al. (2012) 
reports that a steady state is reached after 8-10 days, thus there is discrepancy on how the 
laying-hens handle fat soluble nutrients internally.   
Laying-hens upon birth only have one functional ovary (left) that contains a range 
of 3,600 to 4,000 tiny ova that will develop into the mature yolks of the eggs (Scanes et 
al., 2004).  Upon reaching sexual maturity and release of specific hormones (follicle 
stimulating hormone and luteinizing hormone) an ova (single female reproductive cell) 
starts to mature into a yolk, slowly at the beginning and speeding as release (ovulation) is 
within 8-10 days.  The matured yolk is released from the ovary by a rupture of the follicle 
(stigma).  The released yolk is then engulfed by the oviduct.  The oviduct is broken into 
five parts (infundibulum, magnum, isthmus, uterus, and vagina).  The infundibulum picks 
up the released yolk from the body cavity.  The magnum (without live sperm present) 
deposits think albumen around the yolk (which will later form chalaza and inner 
albumen).  When the forming egg arrives in the isthmus, the inner and outer shell 
membranes are added that give protection from contamination.  In the uterus the albumen 
becomes inflated by added water and minerals and the shell begins to form with calcium 
deposits.  Most of the time in this process is spent in the uterus.  The egg is laid just after 
arrival to the vagina.  Overall, the oviduct receives the yolk from the follicles almost 
daily and forms the albumen network and other various components around the yolk 
(Scanes et al., 2004; Bell et al., 2002).  Abnormalities to this process can produce 
multiple-yolked eggs, yolkless eggs, blood spots, meat spots, dented eggshells, and soft-
shelled eggs. 
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Better understanding of how an egg is laid and how various nutrients are 
deposited into the laying-hen eggs could help further improve the nutritional profile of 
the egg.  Delivery systems could be used to better transport nutrients into the system to be 
distributed in the various organs, tissues, and eggs of the laying-hen.  Having added 
nutrients in eggs could help encourage consumers to increase their consumption of eggs.   
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Abstract: Hens efficiently transfer nutrients from their feed to the eggs.  Tocotrienols 
(T3s) have various health benefits including lowering cholesterol. Annatto is the only 
source of T3s without the presence of α-tocopherol, hence it can be used to study T3 
transfer without the interference of α-tocopherol.  In this study, hens were fed diets for 7 
weeks containing annatto at 100, 500, or 2000 ppm (by weight), and also 2000 ppm 
annatto with 200, 600, or 1000 ppm added α-tocopherol to study the effect of α-
tocopherol on transfer of T3s.  No significant differences were found in egg production or 
properties.  Significant differences (p<0.05) were found in transfer efficiencies of 
tocopherols and T3s to the yolks.  α-Tocopherol was transferred more efficiently (21.19-
49.17%) than γ-T3 (0.50-0.96%) or δ-T3 (0.74-0.93%).  Addition of 1000 ppm of α-
tocopherol decreased the amount of γ-T3 (by 23.76%) but it did not impact the transfer of 
δ-T3 to the egg.  These feeding treatments did not impact the cholesterol content of the 
eggs.   
Keywords: α-tocopherol, annatto, cholesterol, egg, tocotrienols (T3s), transfer efficiency 
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Introduction 
Feeding different diets to laying hens can dramatically change the nutrient 
composition 
1
 and appearance 
2
 of the resulting eggs with minimal changes to 
functionality, making feed supplementation a means of nutrient enrichment or 
modification for the human diet.  Vitamin E is a fat soluble vitamin which has eight 
major forms that are classified into two major groups – tocopherols and tocotrienols 
(T3s), differing in 3 double bonds on the phytyl tail in the T3s.
3
  Each of these groups 
(tocopherols and T3s) has an α, , γ, and δ form varying in the number and placement of 
the methyl groups on the chromanol ring.
3
 
Of these forms, α-tocopherol is the most bioavailable due to the presence of an α-
tocopherol transfer protein in the liver that has specific affinity for the α-tocopherol form 
of vitamin E.
4
  More recently the interest has grown in T3s which have been shown to 
have many health benefits.
5
  One significant benefit is lowering cholesterol by down-
regulating the hepatic enzyme 3-hydroxy-methyglutaryl coenzyme A reductase, a key 
enzyme in cholesterol synthesis.
5-12
  Walde et al.
13
 showed that the addition of barley or 
palm oils to laying-hen feed decreased egg yolk cholesterol by 4 and 6%, respectively, 
but both of these sources have α-tocopherol naturally present, limiting the ability to 
determine the impact the presence or absence of α-tocopherol has on the transfer of the 
T3s.     
Annatto is the only known natural source of T3s (δ ~90% and γ ~10%) without α-
tocopherol present 
14
, making it possible to observe T3 transfer efficiency both in the 
presence and absence of added α-tocopherol.  The absence of α-tocopherol may help 
improve the transfer of the T3s to the resulting egg yolks.  Annatto is naturally derived 
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from the Bixa orellana rainforest plant with high purity and potency commonly used by 
the food industry to give certain dairy products the characteristic yellow color from 
carotenoids (bixin and norbixin) present in the annatto.
14  
 Annatto has been used in 
laying hen feed by Harder et al.
15
 to study cholesterol reduction in eggs, and a reduction 
was observed when annatto was supplemented at above 1.5% in feed.  However, 
McGonigle et al 
16
 did not observe significant difference in the cholesterol content in the 
egg when the laying hen feed was supplemented with annatto at 200-600 ppm levels 
compared to control.      
In order to provide health benefits to the laying-hens or to the egg consumers, we 
wanted to evaluate the transfer efficiency of the T3s from the feed to the egg both in the 
presence and absence of α-tocopherol, and their effect on egg cholesterol content.  The 
hypotheses of this study were that: a) the supplementation of annatto T3s to laying-hen 
feed would increase the level of T3s in the egg yolk, b) the presence of T3s would lower 
the cholesterol levels in laying-hens and consequently lower the cholesterol in the egg 
yolk, and c) the added α-tocopherol would interfere and reduce the transfer of T3s thus 
attenuating the effects of the T3s on egg cholesterol.  It was also hypothesized that the 
supplements would result in minimal changes in the hen production performance and egg 
quality.  
 
Materials and Methods 
Feeding Experiments.  For 7 weeks, 84 laying hens (Hy-Line W-36 breed, 30 weeks of 
age) were fed base diet (Table 1) and diets supplemented with American River 
Nutrition’s DeltaGold® 70 Annatto Tocotrienols and ADM’s α-tocopherol (Table 2).  
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The feeding experiment was approved by the Iowa State University Institutional Animal 
Care and Use Committee (IACUC).  The base diet met the NRC nutrient 
recommendations.
17
  The hens were randomly assigned to a treatment and were kept in an 
environment similar to that of most modern industry laying facilities.  The average 
temperature was 25°C and the average relative humidity was 40%.  The lighting was on 
for 16 hours and off the remaining 8 hours of the day.  Three hens were placed in each 
cage (experimental unit, EU) with 30 cages (10 stacks with 3 tiers per stack) total.  Only 
28 cages were needed to house the 84 laying hens, 2 cages were not used due to air 
velocity difference and failure of eggs to roll to the front causing breakage.  There were 7 
treatments diets (Table 2) with 4 replicates (4 EUs) for each treatment, thus 12 hens per 
treatment diet. Upon arrival to the new environment, the hens were given a week of 
acclimation.  No mortalities occurred during this study.   
Feed Mixing. A horizontal mixer (Precision Horizontal Batch Mixer; H.C. Davis Sons 
MFG. Co., Inc., Bonner Springs, KS) combined the base diet for 30 minutes.  To mix the 
supplements into the base diet, the appropriate amount of annatto and/or α-tocopherol 
was weighed and then was mixed into a small amount of the base diet to ensure it was 
well incorporated.  This mixture was then added to more feed and mixed well with a 
Hobart mixer (model H-600; Hobart, Troy, OH).  This portion was then incorporated into 
to entire diet portion with the same horizontal mixer that was used to mix the base diet.  
Feed was stored at refrigeration temperatures (4°C) away from light and taken to the 
experimental site daily, where hens were fed and watered ad libitum throughout the entire 
study.  Daily measurements taken precisely every 24 hours were feed disappearance and 
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egg production.  Hen body weight was taken weekly as an indicator if the hens were 
eating properly.   
Egg Sampling and Storage.  The eggs were collected daily for the first 2 weeks and 
weekly for the remaining 5 weeks.  Eggs were taken from 2 days and pooled (i.e., day 1 
and day 2 eggs are referred to day 2 eggs in this study).  The sampling days were day 2 
(1-2d), 4 (3-4d), 6 (5-6d), 8 (7-8d), 10 (9-10d), 12 (11-12d), 14 (13-14d), 21 (20-21d), 28 
(27-28d), 35 (34-35d), 42 (41-42d), and 49 (48-49d).  For sample preparation, the egg 
yolks were carefully separated from the albumen and rolled on a paper towel to ensure 
only yolk was taken.  The yolks from one cage over 2 days were homogenized manually 
and a sample was taken and stored at - 4°C until further analyses were carried out.  The 
frozen egg yolks were then freeze-dried (Virtis Genesis 25LE, NY) for at least 72 hours 
to remove the moisture by sublimation to preserve the lipid.      
Physical and Sensory Properties of Eggs and Egg Yolks.  The quality of the eggs 
collected was measured at every sampling time using a high accuracy Digital Egg Tester 
DET6000 (Nabel, Japan).  The measurements taken included whole egg weight (grams), 
eggshell strength (Newton), egg yolk color (Yolk Color Fan, YCF), Haugh Unit 
(calculated from albumin height), and eggshell thickness (millimeters).  The YCF taken 
objectively by this instrument is based on tristimulus values standardized by the 1931 
CIE colormetric according to the instrument manual.   
Trained Sensory Panel Evaluation on Egg Yolk.  To determine if and how different the 
treatment eggs (days 35 and 36) were from the control, 9 panelists were trained in 4 
training sessions to evaluate the egg yolk for yolk color (less to more yellow), moistness 
(low to high), smoothness (lumpy to smooth), chalkiness or mouth drying (none to 
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intense), savory egg yolk flavor (none to intense), bitterness (none to intense), and off-
flavor (none to intense) using a 15 centimeter line scale.  To calibrate the panelists to 
these attributes, anchors were used and included egg yolks from the extreme diets 
(control, T3 2000, and TC 1000) for each scale, YCF for yolk color, and bitterness 
solution of quinine for bitterness.  For sample preparation, eggs were hard boiled, 
consistently cooled using refrigeration, followed by preparation by cutting in half and 
serving to the panelists cut side down on a plate labeled with a random 3 digit code in a 
random order to minimize bias.  The 4 replicates were evaluated on 4 separate days with 
panelist’s scores averaged on each day.   
For all of the remaining analyses, the egg yolk was carefully separated from the 
albumen and analysis was conducted on only the egg yolk.  Viscosity was measured on 
the raw separated egg yolks collected from day 47 using a Haake RS 150 Rheometer 
(ThermoOrion, Karlsruhe, Germany).  This measurement was taken as explained in 
Walker et. al.
2 
 
Chemical Properties of Egg Yolks.  Total Egg Yolk Moisture. The total moisture was 
measured by drying 2 g of yolk in an aluminum dish for 4-5 hours at 105°C as stated in 
AOAC standard method 922.06.  This measurement was done on day 28 yolks after they 
were homogenized.   
Egg Yolk Lipid Extraction. Freeze-dried egg yolk samples were ground with a mortar and 
pestle to reduce particle size, and the yolk was a fine powder.  About 0.5 g sample of the 
ground freeze-dried yolk powder was accurately weighed into a glass vial and mixed with 
5.0 mL of chloroform : methanol (2:1 by vol), similar to the procedure of Folch et al.
18
  
The vials were capped and manually shook for 30 seconds to ensure full dispersion of the 
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solid in the solvent.  The vials were placed in a shaker at ambient temperature overnight, 
then centrifuged to obtain a clear layer.  Approximately 2 mL of the supernatant was 
filtered through a 0.45μm filter (PTFE) with a glass syringe.  The filtrate (1.0 mL) was 
taken precisely and placed in a pre-weighed glass vial, and the solvent was evaporated 
with a nitrogen evaporator to prevent lipid oxidation.  To ensure all of the residual 
solvent was removed, the samples were placed in a vacuum oven at ambient temperature 
overnight.  The vials were weighed to calculate total oil extracted.  The oil was then 
dissolved in HPLC grade hexanes and stored in an explosion proof -20°C freezer until 
further analyses were carried out, including the HPLC quantification of the tocopherols 
and tocotrienols.   
Egg Yolk Phospholipid Composition. 
31
P NMR was used to determine the phospholipid 
profile for day 21 egg yolk samples.  After the egg yolk oil was extracted, a small sample 
(80-120 mg) of oil was taken and prepared as explained by Yao et al.
19
 These samples 
were analyzed for the phospholipid content and class composition in the egg yolk oil.   
Egg Yolk Fatty Acid Composition.  A small sample of egg yolk oil from day 49 was 
converted to fatty acid methyl esters (FAME) by mixing the lipid with one milliliter of 1 
M sodium methoxide at ambient temperature for 5 hours.  The reaction was stopped by 
adding 3 mL of deionized water (DI water).  Two milliliters of hexanes was added to 
extract the FAMEs to the top layer.  The FAMEs samples were then analyzed using GC 
(Hewlett-Packard 5890 Series II) with a FID detector and a capillary column from 
Supelco (Bellefonte, PA) (SP-2340, 60 m long × 0.25 mm internal diameter × 0.2 μm 
film thickness).  The parameters used for the GC quantification were an injector and 
detector temperature of 250°C, oven temperature programmed to start at 100°C and rise 
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4°C/minute to finish at 240°C.  The flow of gases was set as in Walker et al.
2
  A standard 
solution of FAMEs (Nu-Check Prep Inc. GC reference standard 566, MN) was used to 
identify the fatty acid peaks in the egg yolk lipid samples.   
Vitamin E Contents in Egg Yolk. Egg oil was dissolved in appropriate volume of 
HPLC grade hexanes to obtain the vitamin E isomers in the quantifiable region.  HPLC 
was run as explained in Walker et al.
2
  The concentration of tocopherols and tocotrienols 
were determined using normal-phase HPLC with a Luna 3 μ NH2 100 Å, 150 mm × 3.0 
mm column (Phenomenex, Torrance, CA) and fluorescence detection. The separation 
was achieved isocratically using a mobile phase of 98% hexanes and 2% isopropanol. 
Vitamin E Transfer Efficiency to Egg Yolks. The transfer efficiency was calculated 
based on the maximum concentration value reached for each treatment, all of these 
occurred at approximately day 10 .  For this calculation, the amount of supplement that 
theoretically could have been completely or 100% transferred (i.e. the amount of 
supplement provided from feed daily) was calculated based on supplement compositions 
(Table 2), daily feed consumption, laying rate, and egg yolk weight.  The ratio of the 
value quantified and value calculated based on the complete transfer is the transfer 
efficiency.   
Egg Yolk Cholesterol Quantification. To quantify the total cholesterol in the egg yolks, 
a Wako Cholesterol E (Mountain View, CA) kit was used.  The procedure was carried 
out as instructed using 2 mg of freeze-dried egg yolk (weighed with an analytical 
balance) that was mixed with the color reagent provided by the kit.  This mixture was 
shaken and allowed to react for 15 min at 37°C ensuring that all of the yolk was 
uniformly dispersed in solution for blue pigment formation.  The samples were 
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centrifuged to settle the egg yolk particle and the liquid was carefully pipetted into a 
cuvette.  The cuvette was read using a spectrophotometer (Beckman Coulter DU 720 
UV/Vis Spectrophotometer, CA) at 600 nm, using DI water as a blank.  A standard curve 
was constructed each time samples were measured using the standard cholesterol 
provided in the kit to quantify the cholesterol in the egg yolks.     
Statistical Analysis. Statistical analysis was done using JMP Pro (Version 10, SAS 
Institute Inc., Cary, NC).  One-way analysis of variance (ANOVA) was used for mean 
comparisons, and all-pairwise comparisons were done using Tukey’s honest significant 
difference (HSD) at a p = 0.01 (sensory and fatty acid data) or p = 0.05 (all other data).   
 
Results and Discussion 
Hen Production Performance.  The daily feed disappearance, weekly laying rate 
(100 × eggs produced/hens in cage), and weekly averaged hen body weight are shown in 
Table 3.  No significant differences were found among the treatments in the laying rate or 
hen body weight.  The laying rate was over 90% for all diets, and similar to that reported 
in literature.
2,13,20 
 All hens on treatment diets consumed significantly more feed than 
those on the control diet, with no differences among treatments, indicating that the 
annatto additive caused the hens to consume more feed even at the lowest concentration.  
Annatto has a potent red-orange color from bixin and norbixin carotenoids present 
and is traditionally used in many industries for coloring various products.  But due to the 
low lighting in the environment, broad spectrum sight of the laying hens 
21
, and low 
concentration of supplement in the feed with very subtle visual change in color of feed, 
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the cause for the higher feed disappearance is not believed to be associated with the color 
of the additive.   
The pure annatto supplement used was tasted by the researchers upon arrival and 
it had a bitter and fruity taste.  This addition to the feed may have made the feed more 
palatable to the laying-hens causing an increase in the average amount of feed consumed.  
Chickens have been shown to be sensitive to salty or bitter substances.
22
   Not knowing 
how the laying hens perceive the annatto supplement, it is difficult to know exactly what 
caused this increase. The hens consuming more feed but not producing more eggs 
accordingly would lead to higher production costs.  The egg is considered to be the gold 
standard for protein, being the most affordable complete protein 
23
, thus increasing the 
costs of production is not desirable for the industry or egg consumers.  A potential 
application of this supplement may be for broiler chickens for more rapid growth.  Kudo 
et al.
24  
found that broiler chickens had the highest number of taste buds over layer type 
and Rhode Island Red type.  The higher feed consumption likely can lead to faster rate of 
growth and meat production.    
Physical and Sensory Properties of Eggs and Egg Yolks.  No significant differences 
were found in whole egg weight, egg yolk weight, egg shell strength, yolk color, Haugh 
Unit (HU), or egg shell thickness averaged over time (Table 4).  It was expected that 
there would be minimal changes in the physical and quality properties due to the 
supplements.  All HUs on average were greater than 72, indicating that the eggs produced 
in this feeding study were AA eggs by the USDA Grading standards 
25
, and the HUs were 
similar to those found in literature.
2, 26   
Significant differences were found in the yolk 
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viscosity with many of the treatment diets (T3 500, T3 2000, TC 200, and TC 600) being 
significantly lower than the control.   
Kirunda et al.
27
 also reported inconsistent and lower measurements for viscosity 
in diets with vitamin E supplementation.  Environmental or storage conditions may cause 
changes in viscosity, i.e. increasing storage time decreases viscosity 
28
, but all eggs were 
exposed to the same environmental and storage conditions.  In Walker et al. study 
2
, the 
only significant difference in egg yolks supplemented with palm toco concentrate and 
astaxanthin was the emulsification capacity, with a significant decrease with the 
increased level of supplementation.  It was uncertain why a decrease was seen in 
emulsification capacity of the egg yolks, but it was thought to be due to changes in egg 
yolk protein and lipid interactions.  A similar change could have occurred in this study 
due to supplementation.  Egg yolk is a complex system with a large amount of water, 
lipoproteins, and free proteins.  Understanding the changes in viscosity will require 
further compositional and microstructural studies.  Such changes in viscosity may impact 
the egg yolk functionality and its applications.   
Trained Sensory Panel Evaluation on Egg Yolk. A trained sensory panel was carried out 
to determine what changes were perceived by a trained sensory panel, and to determine 
the magnitude of these changes.  No significant differences were perceived in moistness, 
smoothness, chalkiness/mouth drying, bitterness, or off flavor (Table 4).  It is interesting 
to note that a general trend is seen that as the moistness increased, the viscosity decreased 
although not significant.  Although the annatto supplement had bitter, astringent, and 
fruity flavors, these flavors of the pure annatto extract were not transferred to the eggs 
based on the trained sensory panelist’s evaluation.   
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Panelists did perceive the yolks of the TC 200 and TC 600 diets to be 
significantly more yellow than those of the control.  The egg yolk color measured 
instrumentally (Table 4) did not show any significant differences in the color of the raw 
egg, indicating that boiling the eggs may have enhanced the difference in yellow color of 
the yolk.  The scale set by panelists was a narrow range in yellow color with the extremes 
not being unacceptable to a consumer, indicating although a change in yolk color in some 
of the supplemented diets was perceived, it was not seen as a negative quality.  Some 
consumers prefer a more intense yellow or paler yellow egg yolk.  Preferences in egg 
yolk color also vary with geographical and cultural differences, with many consumers 
associating a certain color of egg yolk with level of quality and safety of the eggs.
29, 30.
  
Other studies had shown an increase in the yellow color of egg yolks with annatto 
supplementation 
20, 29
, but the level of supplementation in this study were much lower, 
thus showing much less of an effect on yolk color.   
The savory yolk flavor was perceived to be the lowest in the TC 1000 diet, but the 
level of change is not expected to be unacceptable to the consumers, and may be more 
palatable.  The 15 cm line scales used to train the panelist were not extremely different 
when comparing the extremes across all attributes, so the differences noticed were very 
small in general.  
Chemical Properties of Egg Yolks. Total Egg Yolk Moisture.  There was no significant 
difference among the treatment diets for moisture content (48.30-48.84%).  Moisture 
content of an egg yolk can vary with breeds of chicken, but 48-49% moisture is 
consistent with the dry solids content of 52-53% reported by Varadarajulu et al.
31
.  
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Generally, 50% moisture content is accepted for an egg yolk 
32
,
 
and the values found in 
this study were comparable to this.   
Because significant differences were found in viscosity, it was expected that there 
would be differences in moisture content.  Many of the treatments had lower viscosity 
values than the control, indicating a thinner yolk, which would be attributed to higher 
moisture; but this was not observed.   
Egg Yolk Lipid Content. There was no significant difference among the treatment diets 
for egg yolk lipid content (63.43-64.34%, dry basis, db).  The total lipid found in the egg 
yolks was slightly higher than that found in literature of 62.5% dry basis.
32
  It was 
assumed that the modification of the Folch 
16
 lipid extraction procedure of not using 
water wash step would leave extractable proteins in the lipid extract, thus causing 
theincrease. However, when the traditional Folch wash was carried out for the same egg 
yolk samples, the results were similar to those measured with the modified method.   
Egg Yolk Phospholipid Composition. 
31
P NMR was performed to determine the weight 
percent of phospholipids for egg yolks from day 21.  Peaks in the NMR spectrum were 
identified using methodology from Yao et al.
19
  No significant differences were found 
among treatment diets in any of the phospholipids.  The major phospholipids detected 
were phosphatidylcholine (74.74-75.54%) and phosphatidylethanolamine (19.00-20.25%) 
which are expected in egg yolk.  The total phospholipids in the yolk lipid (21.11-24.94%) 
was comparable with that reported in literature.
2, 32  
Other minor phospholipids in the egg 
yolk samples were phosphatidylinositol (0.82-1.48%), lysophophatidylcholine (1.22-
1.44%), sphingomyelin (1.90-2.47%), and lysophosphatidylethanolamine (0.59-0.80%).  
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Phospholipids have many applications in the food industry 
33
 and are important biological 
molecules in maintaining a healthy body.
34
  
Egg Yolk Fatty Acid Composition.  The fatty acids detected in day 49 yolk samples were 
16:0 (24.37-26.26%), 16:1 (2.04-2.57%), 18:0 (9.29-10.05%), 18:1 (39.53-40.92%), 18:2 
(15.91-17.05%), 20:4 (1.88-2.19%), and 22:6 (0.48-0.60).  There were no significant 
differences in any of the fatty acids reported across any of the treatment diets, and the 
percentages found are similar to that reported in literature.
2, 32, 35
 
Vitamin E Content in Egg Yolk. After 10 days of feeding the supplement diets,  a 
steady state of nutrient transfer of vitamin E to the egg yolk was reached as shown in Fig. 
1, same as reported by Walker et al.
2
  The forms of vitamin E reported in the figure  
include α-tocopherol, γ-T3, and δ-T3 because these are the major forms of vitamin E in 
the supplements added to the feed.  It is evident from the kinetics of the transfer as shown 
in Fig. 1 that α-tocopherol was transferred at a much higher rate than either of the γ or δ -
T3s even when supplemented in similar amounts. 
To understand how the additives were transferred to the yolk, the measurements 
after steady state (day 10 and after) were averaged and compared, as shown in Table 5.  
The diets without α-tocopherol supplemented (Control, T3 100, T3 500, and T3 2000) 
were not significantly different with similar amounts of α-tocopherol as reported by the 
USDA Nutrient Database.
36
  There is α-tocopherol in the base diet and the amount found 
and transfer efficiencies are the same across these treatments.  As expected, the amount 
of α-tocopherol in the egg yolks significantly increased as the amount of α-tocopherol 
added to the feed increased.  At steady state, γ-T3 was the highest in T3 2000, showing 
that α-tocopherol did decrease the amount of γ-T3 transferred, but this was not significant 
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until the use of highest level of α-tocopherol (TC 1000).  This outcome indicates that 
when α-tocopherol is present at a high concentration it lowers the amount of γ-T3 
transferred to the egg yolk from the feed.   
δ-T3 was significantly higher in the diets supplemented with 2000 ppm of 
annatto, with none of the diets supplemented with α-tocopherol being significantly 
different from T3 2000.  Therefore, α-tocopherol did not impact the transfer of δ-T3 as it 
did for γ-T3, and this is believed to be due to the differences and similarities of structure 
between the various forms of vitamin E.  γ-T3 is more structurally similar to α-tocopherol 
(3 methyl groups) with 2 methyl groups on the ring structure but δ-T3 only having 1 
methyl group on the phenolic ring.
3
  α-Tocopherol is reported to interfere with the 
absorption of T3s with a dose-response relationship,
 37
 and this is believed to be due to 
how the various forms of vitamin E are transported and distributed.   
When the supplement diets without α-tocopherol were compared, T3 500 and T3 
2000 diets were significantly higher in γ and δ-T3 than the control and they were 
different from each other.  Thus, it is possible to significantly increase the γ and δ-T3 in 
the egg yolks with increasing annatto supplementation although this was not proportional 
to its concentration in the feed. 
Vitamin E Transfer Efficiency to Egg Yolks. α-Tocopherol was transferred much more 
efficiently (21.19-49.17%) to the egg yolk than either γ (0.50-0.96%) or δ (0.74-0.93%) 
T3s, as reported in Table 6.  Significant decreases in the transfer efficiency of α-
tocopherol were observed when it was supplemented at higher concentration.  Decreases 
in γ-T3 transfer efficiencies were observed after supplementation passed 100 ppm, but 
the efficiency was not impacted by added α-tocopherol.    
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The transfer efficiency for α-tocopherol was much higher than that reported by 
Walker et al. (9.9%) 
2
 and very similar to that reported by Walde et al.(39.59-44.78%). 
13
 
It decreased as more α-tocopherol was added.  This decrease indicates that there was a 
leveling off possibly due to saturation of the α-tocopherol transfer protein (αTTP) in the 
liver that is an important step in the uptake of vitamin E, especially α-tocopherol.   
Tocotrienols had been shown to have poor absorption and transfer to egg yolks in 
the literature previously 
2,13
, thus low transfer efficiencies were not unexpected. The 
transfer efficiency of γ-T3 was higher than those reported by both Walker et al. (<1%) 2 
and Walde et al.(0.37-0.40%).
13 
 δ-T3 was transferred similarly to that reported by 
Walker et al. (<1%) 
2  
but higher than that reported by Walde et al. (0%).
13
   
α-Tocopherol was more efficiently transferred to the yolk and this was expected 
due to the presence of an αTTP in the liver which preferentially binds α-tocopherol 
making it more bioavailable.
4
  When the highest T3 diet, T3 2000, is compared with the 
TC diets, no significant differences are found, indicating that adding more α-tocopherol 
did not impact the transfer efficiency of γ-T3.  This can also be seen in δ-T3 with no 
significant differences among the treatment diets.  This trend was expected because α-
tocopherol dominated the αTTP causing the T3s to be mostly excreted.  Overall, it was 
observed that the annatto T3s were not well absorbed with high concentration detected in 
the manure (shown in another paper to be published in Poultry Science), showing a need 
for a better carrier system or matrix to transport the T3s into the body.  
 Egg Yolk Cholesterol Quantification.  The amount of cholesterol in day 2, 21, and 49 
yolks was determined spectrophotometrically, and the results are shown in Table 7.  This 
method was a modification using a cholesterol quantification kit designed for biological 
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samples, especially blood serum.  To validate this method, various tests were performed 
to ensure this method was accurate and appropriate.  With the freeze-dried egg yolk being 
a mass of solid particles the concern was length of time for the reaction to reach 
completion.  A time lapse study was done to ensure that all cholesterol preset in the egg 
yolk powder reacted fully.  It was observed that at 15 min (3 times longer than required 
by kit) the ratio of the absorbance to mass of freeze-dried egg yolk reached a constant and 
it did not change significantly after 15 min.   
Using an average of the egg yolk weights (14.61g/ yolk), the range of cholesterol 
in the yolks was 192-231 mg per yolk.  This amount is in general consistent with values 
reported in the literature. 
39-41
  Kazmierska et al.
41
 discussed how different techniques for 
quantifying cholesterol gave slightly different results.  For this reason, AOCS’ 
saponification then GC method (Ca 6b-53) was done on selected treatments (control and 
T3 2000) to compare the amount of cholesterol quantified.  No significant differences 
were detected among treatments.  It was noted that the kit used in this study resulted in 
18.37-20.63% higher values than the AOCS saponification and GC method, possibly due 
to complete quantification of all cholesterol forms.  The kit method in this study allowed 
for detection of both free cholesterol and cholesterol ester, with the enzyme cholesterol 
ester hydrolase freeing cholesterol esters to allow for total quantification.  
It is well known that cholesterol ester takes longer to free the cholesterol during 
saponification compared to the hydrolysis of other lipid ester bonds.
42
  It is not well 
understood how the amount of cholesterol changes (i.e. hydrolysis of ester or degradation 
of the sterol) under conditions of heat and high pH during saponification.  Busch et al.
43
 
reported that cholesterol was heat labile at 45°C in the presence of 1M KOH, which are 
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conditions typically milder than that used in various cholesterol quantification 
procedures.  Egg yolks were reported to have 10-15% of the cholesterol present as esters. 
44 
 If the ester hydrolysis was incomplete or there was free cholesterol degradation during 
the saponification, the standard AOCS method would lead to an underestimation of the 
total cholesterol content.   
In reporting the amount of cholesterol in an egg it is important to specify the 
weight size class of the egg (peewee, small, medium, large, extra-large, or jumbo).
25
  The 
average egg weight found in this study was 59.69 ± 0.37 g (with shell).  According to the 
USDA nutrient database 
36
 a large egg is 50 g and an extra-large egg is 56 g at a 
minimum without shell, so it is most appropriate to use the USDA grading manual 
25 
(weights with shells included) to categorize the eggs with shell in this study.  According 
to these standards, the eggs in this study are large eggs.   USDA reports the yolk of a 
large egg to be 17 g, much larger than the average in this study (14.61 g).  Our yolk 
weight is very accurate because any attached egg albumen outside the yolk was removed 
with paper towels.  It is evident that based on weight for the large egg class and its yolk 
size as determined in this study, the amount of cholesterol reported by the USDA nutrient 
database, 184 mg/large yolk or 12.6 mg cholesterol/g yolk as-is, is lower than that found 
in this study, 14.4 mg cholesterol/g yolk as-is average across all treatments and days.  
The reasons for this differences is discussed above. 
  No significant cholesterol reductions over the feeding study were seen across 
any treatment diets.  Walde et al.
13
 found a 4% or 6% reduction in diets supplemented 
with barley or palm T3s, respectively; but this trend was not seen in this study.  A key 
difference in this study and the study by Walde et al.
 13
 is the form and amount of T3s 
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present in the sources.  Barley had a mixed tocopherols and T3s, with -T3 being the 
dominant form.  Whereas, palm also contained mixed tocopherols, with -T3 being the 
dominant molecule.  Even though egg from this study can contain up to a similar level of 
total T3 (~100 g/egg) as that of Walde et al, we did not observe cholesterol reduction.  
Harder et al 
15
 also observed lower cholesterol content in eggs with higher levels of 
supplemented annatto in the feed, particularly above 1.5% supplementation.  However, 
there was no information on the T3 content in the annatto.  Nonetheless, McGonigle et al 
16
 observed no significant difference in the cholesterol content in eggs when feed was 
supplemented with annatto, similar to the observation in this study.      
T3s have been shown to lower cholesterol levels in many studies. 
5-12 
  Yu et al.
12
 
showed that  supplementing of 50-2000 ppm of δ and γ T3s in young female chickens 
caused decreases in total serum cholesterol (32%), LDL levels (66%), and TAGs, with 
minimal changes to HDL cholesterol.  In our study, blood samples were taken from the 
hens at day 49 of our feeding trial (37 weeks old)and they also showed no significant 
changes in the lipid chemistry (total cholesterol, HDL, and TAGs, data reported in 
Hansen et al., manuscript under review for publication in Poultry Science).  We do not 
know the cause of the different outcomes, but thought that the use of young female birds 
vs. adult laying hens may play a role in these differences. 
 
Conclusions 
In summary, annatto and α-tocopherol supplements did not significantly impact 
most of the hen performance indicators and quality parameters of the resulting egg yolks.  
Significant differences were found in the daily feed disappearance, egg yolk viscosity, 
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sensory yolk color and savory yolk flavor, and in the amount and transfer efficiency of 
the various forms of vitamin E in the egg yolks.  Based on both the data over time and 
transfer efficiencies at the maximum value for α-tocopherol, γ-T3, and δ-T3, it is evident 
that α-tocopherol is much better transferred to hen egg yolks and does play some role in 
how the other forms of vitamin E are absorbed. This study confirms that the T3s cannot 
be substantially transferred in hen’s body and yolk, even when this is no significant 
amount of -tocopherol present to compete with the binding protein.  This study 
illustrates that by changing what is in laying-hen feed, it is possible to change the 
nutrients in an egg, but only when the physiology of the animals allows.  Novel 
approaches have to be designed to overcome the physiology barrier in order to make the 
hens more efficiently transfer the T3s to the egg.  With a better delivery system it may be 
possible to observe cholesterol reduction effect of the T3s in egg.     
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Tables and Figures 
 
Table 1. Composition of base diet fed to laying-hens for 7 weeks 
Ingredient                                                                                                                                        Amount (%) 
Corn 61.00 
Soybean meal 24.43 
Calcium carbonate (coarse) 5.84 
Calcium carbonate (fine) 3.90 
Dicalcium phosphate 2.02 
Animal rendered oil 1.57 
Vitamin and trace mineral premix 
a
 0.68 
Sodium chloride 0.38 
DL-methionine 0.18 
Calculated Composition % 
Crude protein 16.05 
Crude fat 3.94 
Linoleic acid 1.82 
Calcium 4.20 
Phosphorus (nonphytate) 0.48 
Sodium chloride 0.18 
Chloride 0.26 
Lysine (digestible) 0.77 
Methionine (digestible) 0.41 
Methionine + cysteine (digestible) 0.63 
Metabolizable Energy (kcal/kg) 2,825 
a
 Premix includes (per kilogram of diet): vitamin A, 9000 IU; vitamin D3, 3000 IU; vitamin E, 20 IU; 
cobalamine, 13 μg; riboflavin, 6 mg; niacin, 45 mg; pantothenic acid, 12 mg; choline, 487 mg; menadione, 
1.2 mg; folic acid, 1.5 mg; pyridoxine, 1.2 mg; thiamine, 1.5 mg; biotin, 45 μg; magnesium, 136 mg; 
manganese, 136 mg; zinc, 136 mg; iron, 140 mg; copper, 14 mg; and selenium, 0.27 mg.  
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Table 2. Concentration of annatto and α-tocopherol (TC) in supplemented diets  
Diet Annatto 
a
 (ppm) α-Tocopherol b (TC, ppm) 
Control 0 0 
T3 100 100 0 
T3 500 500 0 
T3 2000 2000 0 
TC 200 2000 200 
TC 600 2000 600 
TC 1000 2000 1000 
a
 DeltaGold® 70 Annatto Tocotrienols: total tocotrienols, 74.5% (δ-tocotrienol 89.2%, 
γ-tocotrienol 10.8%, and other tocotrienols/tocopherols <1%). 
bADM α-Tocopherol: α-tocopherol, 96.6%. 
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Table 3. Hen performance and laying rate for diets with different levels of annatto 
tocotrienols (T3) and α-tocopherol (TC) supplementation (n=4) a 
 Diets 
b
 Daily feed 
disappearance  
(g/day/hen) 
Laying Rate 
(%) 
Weekly Hen Weight 
d
 
(kg/hen) 
Control 103.16 ± 6.28 B 94.56 ± 0.96 1.50 ± 0.02 
T3 100 107.85 ± 5.05 A 94.90 ± 2.86 1.49 ± 0.03 
T3 500 107.43 ± 4.75 A 97.62 ± 3.26 1.50 ± 0.03 
T3 2000 108.28 ± 4.87 A 94.73 ± 2.96 1.48 ± 0.04 
TC 200 107.14 ± 6.49 A 96.94 ± 2.39 1.48 ± 0.03 
TC 600 107.54 ± 5.20 A 94.39 ± 3.66 1.50 ± 0.03 
TC 1000 106.76 ± 6.39 A 96.43 ± 1.70 1.49 ± 0.02 
Significance 
c
 * NS NS 
a 
Values are means ± standard deviations.  
b 
Diets detailed in Table 2. T3 = ppm annatto, TC = ppm α-
tocopherol with constant 2000 ppm annatto. 
c 
Different letters (comparing all treatments) in the same 
column indicate significant differences at the 95% confidence level. NS, not significant at 5%.  
d 
Hen 
weights taken weekly and averaged over 7 weeks. 
 
 
  
 
5
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Table 4. Egg and egg yolk quality properties and sensory attributes of boiled eggs from laying-hen diets with different levels 
of annatto tocotrienols (T3) and α-tocopherol (TC) supplementation (n=4) a 
 
 
 
Diets 
b
 
 
Whole Egg Weight 
(g) 
 
Egg Yolk Weight 
(g) 
 
Egg Shell 
Strength 
(N) 
 
Yolk Color 
(YFC) 
 
Haugh Unit 
(HU) 
 
Egg Shell 
Thickness 
(mm) 
 
 
Yolk Viscosity 
(kg/s m) 
 
Control 59.71 ± 2.03  14.47 ± 0.22 37.37 ± 1.84  4.9 ± 0.07  89.44 ± 1.09  0.36 ± 0.01 0.93 ± 0.19 A 
T3 100 59.87 ± 1.33  14.71 ± 0.31 39.87 ± 3.00  4.9 ± 0.19  89.47 ± 1.42  0.36 ± 0.01 0.74 ± 0.12 A,B 
T3 500 59.14 ± 1.43 14.49 ± 0.38 37.44 ± 3.45  5.0 ± 0.14  89.70 ± 2.28  0.35 ± 0.01 0.59 ± 0.10 B 
T3 2000 59.74 ± 0.65 14.70 ± 0.16 37.48 ± 3.17  5.1 ± 0.18  87.35 ± 1.45  0.35 ± 0.01 0.65 ± 0.12 B 
TC 200 59.44 ± 1.07  14.64 ± 0.14 40.69 ± 3.06  5.2 ± 0.14  86.96 ± 2.10  0.37 ± 0.01 0.50 ± 0.14 B 
TC 600 60.32 ± 1.16  14.89 ± 0.14  36.39 ± 1.38  5.1 ± 0.15  87.88 ± 1.13  0.35 ± 0.01 0.63 ± 0.07 B 
TC 1000 59.58 ± 0.84  14.42 ± 0.48 38.92 ± 1.52  5.0 ± 0.16  88.84 ± 1.57  0.35 ± 0.01 0.69 ± 0.06 A,B 
Significance 
c
 NS NS NS NS NS NS * 
        
Diets 
b
  
Yellow Color 
 
 
Moistness 
 
Smoothness 
 
Chalk/ Mouth Drying 
 
Savory Yolk  
Flavor 
 
 
Bitterness 
 
Off flavor 
Control 6.3 ± 0.6 B 5.2 ± 0.9 8.6 ± 1.0 5.5 ± 1.2 5.7 ± 0.2 A,B 0.3 ± 0.4 0.2 ± 0.3 
T3 100 6.8 ± 0.7 A,B 5.6 ± 1.4 9.5 ± 1.2 4.1 ± 0.4 5.5 ± 0.3 A,B 0.1 ± 0.1 0.2 ± 0.2 
T3 500 6.9 ± 0.3 A,B 6.3 ± 1.4 8.9 ± 0.6 4.4 ± 0.4 5.3 ± 1.1 A,B 0.6 ± 0.6 0.5 ± 0.5 
T3 2000 7.5 ± 0.2 A,B 6.2 ± 1.2 8.2 ± 1.2 4.0 ± 1.5 6.5 ± 1.0 A 0.4 ± 0.3 0.1 ± 0.1 
TC 200 8.3 ± 1.0 A 5.7 ± 0.4 8.9 ± 0.9 4.5 ± 0.4 6.4 ± 0.5 A 0.6 ± 0.9 0.1 ± 0.1 
TC 600 8.3 ± 0.9 A 5.4 ± 0.9 9.1 ± 0.9 4.6 ± 0.4 6.7 ± 0.5 A 0.8 ± 0.9 0.1 ± 0.1 
TC 1000 6.7 ± 0.4 A,B 5.2 ± 1.0 8.6 ± 0.6 5.2 ± 0.5 4.4 ± 0.5 B 0.1 ± 0.1 0.5 ± 0.6 
Significance 
c
 ** NS NS NS ** NS NS 
a 
Values are means ± standard deviations.  
b Diets detailed in Table 2. T3 = ppm annatto, TC = ppm α-tocopherol with constant 2000 ppm annatto. c Different 
letters (comparing all treatments) in the same column indicate significant differences at the 99% confidence level. NS, not significant at 1%.   
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Table 5. Average concentration of vitamin E isomers in egg yolks after reaching steady 
state (day 10 to 49) from diets with different levels of annatto tocotrienols (T3) and α-
tocopherol (TC) supplementation (n=4) 
a
 
Diets 
b
 
α-Tocopherol  
 (μg/g yolk as-is) 
γ-T3 
(μg/g yolk as-is) 
δ-T3  
(μg/g yolk as-is) 
Control 29.15 ± 6.39 D  0.21 ± 0.01 C, c 0.09 ± 0.18 B, c 
T3 100 33.64 ± 2.62 D  0.39 ± 0.04 C, bc 0.43 ± 0.06 B, c 
T3 500 30.71 ± 3.04 D,  1.35 ± 0.23 C, b 2.43 ± 0.32 B, b 
T3 2000 34.21 ± 3.66 D,  6.06 ± 0.95 A, a 11.35 ± 1.84 A, a 
TC 200 347.49 ± 4.71 C,  5.06 ± 0.49 AB 10.69 ± 1.81 A 
TC 600 824.63 ± 94.56 B,  4.98 ± 1.16 AB 9.97 ± 1.91 A 
TC 1000 1285.40 ± 94.96 A,  4.62 ± 0.36 B 9.49 ± 0.56 A 
Significance 
c
 * * * 
a 
Values are means of values from day 10, 12,14, 21, 28, 35, 42, and 49 ± standard deviations.  
b 
Diets detailed 
in Table 2. T3 = ppm annatto, TC = ppm α-tocopherol with constant 2000 ppm annatto. c Different uppercase 
letters (comparing all treatments), lowercase letters (comparing control, T3 100, T3 500, and T3 2000), and 
Greek letters (comparing T3 2000, TC 200, TC 600, and TC 1000) in the same column indicate significant 
differences at the 95% confidence level.  
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Table 6. Nutrient transfer efficiency of vitamin E isomers into egg yolks from feed with 
different levels of annatto tocotrienols (T3) and α-tocopherol (TC) supplementation (n=4) 
a
 
Diets 
b
 α-Tocopherol γ-T3 δ-T3 
Control 39.50 ± 5.01 A N/A N/A 
T3 100 46.89 ± 7.82 A 0.96 ± 0.32 A 0.74 ± 0.45 
T3 500 41.60 ± 5.71 A 0.60 ± 0.12 A,B 0.81 ± 0.49 
T3 2000  49.17 ± 7.62 A, α 0.67 ± 0.12 A,B 0.93 ± 0.54 
TC 200 26.91 ± 2.19 B, β 0.56 ± 0.08 B 0.90 ± 056 
TC 600 21.19 ± 2.52 B, β 0.53 ± 0.10 B 0.79 ± 0.44 
TC 1000 21.42 ± 3.16 B, β 0.50 ± 0.06 B 0.80 ± 0.47 
Significance 
c 
 * * NS 
a 
Values are means at maximum value ± standard deviations.  
b 
Diets detailed in Table 2. T3 = 
ppm annatto, TC = ppm α-tocopherol with constant 2000 ppm annatto. c Different uppercase 
letters (comparing all treatments), and Greek letters (comparing T3 2000, TC 200, TC 600, 
and TC 1000) in the same column indicate significant differences at the 95% confidence level. 
NS, not significant at 5%.   
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Table 7. Cholesterol content of day 2, 21, and 49 egg yolks from diets with different 
levels of annatto tocotrienols (T3) and α-tocopherol (TC) supplementation (n=4) a 
 
Diets 
b
 
 
Day 2  
 
 (mg Cholesterol/ 
g yolk as-is) 
 
Day 21  
 
 (mg Cholesterol/ 
g yolk as-is) 
 
 
Day 49 
   
(mg Cholesterol/ 
g yolk as-is) 
 
Control  14.62 ± 1.64 14.61 ± 1.22 14.87 ± 0.49 
T3 100 14.71 ± 1.74 15.80 ± 2.93 15.21 ± 1.71 
T3 500 14.09 ± 1.32 14.60 ± 1.13 14.37 ± 1.03 
T3 2000 15.18 ± 1.41 14.37 ± 1.03 14.46 ± 0.25 
TC 200 13.68 ± 0.96 13.20 ± 1.50 13.49 ± 0.92 
TC 600 14.90 ± 0.68 15.52 ± 1.43 13.52 ± 0.45 
TC 1000 14.71 ± 1.43 13.24 ± 1.21 13.94 ± 1.42 
Significance 
c
 NS NS NS 
a 
Values are means ± standard deviations.  
b 
Diets detailed in Table 
2. T3 = ppm annatto, TC = ppm α-tocopherol with constant 2000 
ppm annatto. 
c
NS, not significant at 5%.   
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Figure 1. Kinetics of α-tocopherol, γ-T3, and δ-T3 accumulation in egg yolk over 7 week 
feeding period, showing means and standard deviation bars (n=4). Diets detailed in Table 
2. T3 = ppm annatto, TC = ppm α-tocopherol with constant 2000 ppm annatto. 
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Abstract  
The impact of supplementing laying hen feed with annatto tocotrienols (T3s) and 
alpha-tocopherol on the distribution of various forms of vitamin E and cholesterol 
throughout the hen’s body was evaluated.  A total of 18 organs or tissues (skin, fat pad, 
liver and gall bladder, heart, oviduct, forming yolk, laid yolk, lungs, spleen, kidney, 
pancreas, gizzard, digestive tract, brain, thigh, breast, manure, and blood) were collected 
after 7 weeks of feeding on diets enriched with various levels of alpha-tocopherol and 
annatto extract that contained gamma-T3 and delta-T3.  Tissue weights, contents of 
moisture, lipid, alpha-tocopherol, gamma-T3, delta-T3, cholesterol, and fatty acid 
composition of extracted lipids from the collected organs and tissues were determined.  
Tissue weight, moisture content, and lipid content did not change significantly with feed 
supplementation treatments, except that the liver became heavier with increased level of 
supplementation.  Minimal changes were found in the fatty acid composition, except in 
the fat pad, oviduct, brain, and manure.  Overall, the main organs that accumulated the 
supplemented vitamin E were fat pad, liver and gall bladder, oviduct, forming yolks, laid 
yolks, kidney, brain, thigh, and breast.  Much of annatto gamma-T3 and delta-T3 was 
found in the manure indicating most was excreted (>90%). In some tissues (brain and 
oviduct,) a significant increase in polyunsaturated fatty acids was seen with increased 
supplementation.   Alpha-tocopherol impacted the transfer of gamma-T3 to forming and 
laid yolks, but did not impact delta-T3 transfer.  No significant differences were found in 
most of the tissues in cholesterol, except a reduction in heart based on tissue as-is.  Blood 
samples showed large variances in individual hens with no significant differences in total 
cholesterol, HDL, or total triacylglycerols.  Supplementing feed with annatto T3s and 
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alpha-tocopherol showed that the vitamin E profile and distribution of the laying hen 
body can be altered to different extents depending on tissue.  
Key words: Alpha-tocopherol, fatty acid composition, cholesterol, tocotrienols (T3s), tissue and 
organ, vitamin E distribution   
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Introduction 
Vitamin E is a fat soluble vitamin which has eight major forms that are classified 
into two major groups, tocopherols and tocotrienols (T3s).  These two groups differ in 3 
double bonds (unsaturation) on the phytyl tail in the T3s, making the T3s structure more 
rigid (Sontag and Parker, 2007).  Each of these groups (tocopherols and T3s) has an 
alpha, beta, gamma, and delta form varying in the number and placement of the methyl 
groups on the chromanol ring (Sontag and Parker, 2007).  Of these forms, alpha-
tocopherol is the most bioavailable form due to the presence of an alpha-tocopherol 
transfer protein in the liver that has higher affinity for alpha-tocopherol, causing 
biodiscrimination against other forms of vitamin E (Traber et al., 1999). 
Vitamin E is first absorbed from the small intestine and packaged into a 
chylomicron with other hydrophobic constituents from the diet.  It is then transported to 
the liver.  In laying hens the uptake of lipid substances from the diet occurs slightly 
different than that of humans.  Lipids, including vitamin E, are delivered to liver by 
portomicrons (lipid rich proteins released by intestine) through the portal vein (Surai et 
al., 2001) due to the lack of a lymph system.  In the liver, the alpha-tocopherol transfer 
protein selectively and preferentially binds to alpha-tocopherol and it is further 
distributed to other parts of the body, while the majority of the other forms are excreted 
(National Academy of Sciences, 2000).  Even though alpha-tocopherol is the most 
bioavailable form, the other forms of vitamin E are also important in the body, and they 
may be absorbed under certain conditions, such as when alpha-tocopherol is absent.     
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Interest has grown in T3s which have been shown to have many health benefits.  
They are higher potency antioxidant than tocopherol counterparts, anti-tumor, and can 
lower the risk of heart disease and hypertension (Yang et al., 2013; Qureshi et al., 2000).  
One significant benefit of the T3s is lowering cholesterol by down-regulating the hepatic 
enzyme (3-hydroxy-menthy-glutaryl coenzyme A reductase), the rate limiting enzyme in 
cholesterol synthesis (Qureshi et al., 1986; Pearce et al., 1992; Parker et al., 1993; 
Qureshi et al., 2000; Qureshi and Peterson, 2001; Qureshi et al., 2001; Yu et al., 2006; 
Yang et al., 2013).   
Annatto is naturally derived from a rainforest plant (Bixa Orellana).  The 
carotenoids (bixin and norbixin) present in the annatto are commonly used by the food 
industry to color certain dairy products (Frega et al., 1998).  
  
Annatto extract is the only 
known natural source of T3s (~90% delta and ~10% gamma) without the presence of 
alpha-tocopherol (Frega et al., 1998), making it possible to observe T3 transfer both in 
the presence and absence of alpha-tocopherol.  We hypothesized that the absence of 
alpha-tocopherol may help improve the transfer of the T3s.   
Previously, we have shown that by supplementing laying hen feed with annatto 
and alpha-tocopherol, the amount of alpha-tocopherol, gamma-T3, and delta-T3 can be 
significantly increased in the eggs laid with minimal changes to the egg yolk quality 
(Hansen et al., 2014).  We want to understand further how these compounds are 
distributed throughout the hen’s body.  Knowing how the laying hens accumulate these 
nutrients, the compositional and nutritional properties of various organs and tissues may 
be better understood.  This may have significant implications for the broiler chicken 
industry.  This work is the continuation of the study of impact of annatto supplementation 
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on quality of eggs (Hansen et al., 2014), and it is the first of its kind to examine a 
complete set of organ and tissue samples (18 total) from birds for their lipid composition 
profiles.    
        We hypothesized that organs (especially liver) that are important in vitamin E uptake 
and absorption will show increases in the amounts of the vitamin E with feed 
supplementation (alpha-tocopherol, gamma-T3, and delta-T3), and will show decreases in 
the amount of cholesterol due an increased level of T3s.       
Materials and Methods 
Feeding Experiment 
For 7 weeks, 48 laying hens (Hy-Line W-36, 30 weeks of age) were fed a base 
diet (Table 1) supplemented with American River Nutrition’s (Hadley, MA) DeltaGold® 
70 Annatto tocotrienols and ADM’s alpha-tocopherol (Table 2).  The base diet met the 
NRC nutrient recommendations (NRC, 1994). The feeding experiment was approved by 
the Iowa State University Institutional Animal Care and Use Committee (IACUC).  The 
hens were randomly assigned to a treatment and were kept in an environment similar to 
that experienced in most conventional laying facilities.  The average temperature was 
25°C and the average relative humidity was 40% over the 7 week feeding period.  The 
lighting was on for 16 hours and off the remaining 8 hours of the day.  Three hens were 
placed in each cage (experimental unit, EU) with 16 cages (10 stacks with 3 tiers per 
stack) total.  There were 4 treatment diets (Table 2) with 4 replicates for each treatment, 
thus 12 hens per treatment diet.  Upon arrival to the new environment, the hens were 
given a week of acclimation.  No mortalities occurred during this study.   
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Feed preparation was described by Hansen et al. (2014).  Feed was stored at 
refrigeration temperature (4°C) away from light and taken to the experimental site daily, 
where hens were fed ad libitum and watered daily to ensure both were in excess 
throughout the entire study.  Daily measurements taken precisely every 24 hours were 
feed intake and egg production.  Hen body weight was taken weekly as an indicator of 
the hens proper feed intake.   
Manure and Organ Sampling and Storage 
Manure was collected on day 43 from all treatment diets.  The manure from each 
cage was homogenized and a 50g sample was taken and frozen until further analyses 
were carried out.   
Hens were euthanized using injection of pentobarbital sodium (390 mg/ml) by 
ISU veterinary medical professionals after day 49 of the feeding study.  Blood samples 
were taken just prior to euthanization for lipid chemistry analysis.  The hen carcasses 
were briefly scalded in hot water, de-feathered, and stored at refrigeration temperature 
(4°C) until the next day when the remaining 15 organ samples (blood, manure, and laid 
yolks were previous collected) were harvested and weighed (skin, fat pad, liver and gall 
bladder, heart, oviduct, forming yolk, lungs, spleen, kidney, pancreas, gizzard, digestive 
tract, brain, thigh, and breast).  The organ and tissue samples were frozen until further 
analyses were carried out.  The frozen organ and manure samples were ground using 
blenders at highest speed and re-frozen.   
Blood samples were taken from 2 of the 3 hens at random from each cage from all 
treatments.  The samples were taken to the ISU Veterinary Pathology Services laboratory 
for quantification of total cholesterol, HDL, and TAGs.  A VITROS cholesterol slide 
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method was used to determine total cholesterol. A drop of hen blood serum was placed 
on a slide and spread into an even layer to expose to enzymes for cholesterol esters 
hydrolysis, cholesterol oxidation, and production of a color pigment.  The density of the 
color pigment formed is proportional to the concentration of cholesterol, and is read 
colorimetrically at 540 nm.  A similar method was used for HDL quantification with the 
appropriate reagent that selectively dissociates cholesterol from HDL lipoproteins and is 
quantified colorimetrically at 670 nm.  The triacylglycerols (TAGs) were quantified using 
a slide method that dissociates TAGs from lipoproteins in the blood serum, and then the 
TAGs are hydrolyzed to glycerol and fatty acids.  Glycerol is phosphorylated, oxidized to 
form a dye that is read colorimetrically at 540 nm.  These methods used are explained in 
more detail by Allain et al (1974) for total cholesterol and HDL and Spayd et al. (1978) 
for TAG.   
Composition of Organs and Tissues 
Organ Weights.  Upon dissection, organs were collected and weighed to allow for 
proper calculations and comparisons among treatments.  The organs were then frozen at - 
4°C until further processing was carried out.  The frozen organ samples and manure were 
then freeze-dried (Virtis Genesis 25LE, NY) for at least 5 days to remove the moisture by 
sublimation to preserve the lipid and facilitate lipid extraction.      
Total Moisture. The total moisture was measured by drying 2 g of sample in an 
aluminum dish for 4-5 hours at 105°C (AOAC method 922.06).  This measurement was 
done for all organs except the manure (75% moisture used for calculations as determined 
in our previous research).   
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Lipid Extraction. Freeze-dried organ and tissue samples were ground using a 
mortar and pestle to reduce particle size.  A small amount of sample (0.5-3g, depending 
on oil content) of the ground sample was accurately weighed and placed into a glass vial 
and mixed with chloroform:methanol (2:1 by vol), similar to the procedure of Folch et al 
(1957).
 
 The vials were capped and manually mixed for 30 seconds to ensure full 
dispersion of the solid in the solvent.  The vials were placed in a shaker at ambient 
temperature overnight, then centrifuged to obtain a clear solvent layer.  A large portion of 
the supernatant was filtered through a 0.45μm filter (PTFE) with a glass syringe.  The 
filtrate was taken precisely (at varying volumes depending on lipid content of each 
sample) and placed in a pre-weighed glass vial, and the solvent was evaporated with a 
nitrogen evaporator to prevent lipid oxidation.  To ensure all of the residual solvent was 
removed from the sample, the vials were placed in a vacuum oven at ambient temperature 
overnight.  The vials were weighed to calculate total lipid extracted.  The lipid was then 
dissolved in HPLC grade hexanes and stored in an explosion proof -20°C freezer until 
further analyses were carried out, including the HPLC quantification of the tocopherols 
and T3s.  Excess supernatant was stored for other analyses.     
Fatty Acid Composition.  A small sample of the extracted lipid was converted to 
fatty acid methyl esters (FAME) by mixing the lipid with one milliliter of 1 M sodium 
methoxide at ambient temperature for 5 hours.  Some samples were reacted using acidic 
conditions (3% sulfuric acid in methanol) at 85°C overnight due to possible high free 
fatty acid content.  The reaction was stopped by adding 3mL of DI water.  Two milliliters 
of hexanes was added to extract the FAMEs to the top layer.  The FAME samples were 
then analyzed using GC (Hewlett-Packard 5890 Series II) with a FID detector and fused 
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silica capillary column (SP-2340, 60m long x 0.25mm internal diameter x 0.2μm film 
thickness) from Supelco (Bellefonte, PA).  The parameters used for the GC quantification 
were: injector and detector temperature of 250°C, oven temperature programmed to start 
at 100°C and rise 4°C/minute to finish at 240°C.  The flow of gases was set as in Walker 
et al. (2012).  A standard solution of FAMEs (Nu-Check Prep Inc. GC reference standard 
566, MN) was used to identify the fatty acid peaks.   
Vitamin E Quantification 
Organ and manure lipids were dissolved in appropriate volume of HPLC grade 
hexanes to obtain the vitamin E isomers in a quantifiable region.  HPLC was run as 
explained in Walker et al (2012).  The concentration of tocopherols and T3s were 
determined using normal-phase column of Luna 3 μ NH2 100 Å, 150 mm × 3.0 mm and a 
fluorescence detector. The separation was achieved isocratically using a mobile phase of 
98% hexanes and 2% isopropanol. 
Vitamin E Mass Distribution Calculation 
 In order to understand how the distribution of the various forms of vitamin E is 
changed due to supplementation, the mass distribution percentage was calculated.  The 
total weight of a particular form of vitamin E was determined in all organs and tissues 
and each individual weight for each organ was taken as a percentage of the total.  Manure 
was excluded from this distribution calculation because it would skew that data 
significantly and make the distribution difficult to be seen.   
Cholesterol Quantification 
To quantify the total cholesterol in the samples, a Wako Cholesterol E (Mountain 
View, CA) kit was used.  The procedure was carried out as instructed using a small 
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amount of organ (amount depended on cholesterol content) that was mixed with the color 
reagent provided by the kit.  This mixture was shaken and allowed to react for 15min at 
37°C, ensuring that the entire sample was uniformly dispersed for blue pigment 
formation.  The samples were centrifuged to settle the particles and the liquid was 
carefully pipetted into a cuvette.  The absorption was read using a spectrophotometer 
(Beckman Coulter DU 720 UV/Vis Spectrophotometer, CA) at 600nm, using DI water as 
a blank.  A standard curve was constructed each time samples were measured using the 
standard cholesterol provided in the kit to quantify the cholesterol in the organ and tissue 
samples.  More detail and discussion on validation of this method can be found in Hansen 
et al. (2014).     
Statistical Analysis 
Statistical analysis was done using JMP Pro (Version 10, SAS Institute Inc., Cary, 
NC).  One-way analysis of variance (ANOVA) was used for mean comparisons, and all-
pairwise comparisons were done using Tukey honestly significant difference (HSD) at a 
p = 0.01 (cholesterol and fatty acid) and p = 0.05 (all other measurements).   
Results and Discussion 
           In many of the measurements, large variances were observed.  These are believed 
to be mainly due to biological differences naturally occurring among the hens.  Each 
treatment had 4 replicates, with each replicate being a cage of 3 hens.  The cage is the 
experimental unit (EU), and combining the organs and tissues from one EU should have 
reduced the variance.  However, large individual differences still existed as shown in 
individual bird’s blood chemistry done by the certified laboratory.  For all of our own 
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analytical methods, we had coefficients of variation less than 5% for repeated 
measurements of the same sample.    
 During the feeding study, hens performed well with no significant differences in laying rates                                                                                                                                                                                                                                                                                                                                                                                               
(94-98%).  There were also no significant changes in hen weights taken weekly (1.48-
1.50 kg/hen).  An interesting trend was observed that all of the treatment diets (with 
added annatto) led to significantly more feed intake than the control (103.16 g/day/hen 
for control and as high as 108.28 g/day/hen for supplemented diets).  More details on hen 
performance and egg quality are presented in Hansen et al. (2014).   
Compositional Properties of Organs and Tissues as Affected by Feeding Treatment 
Organ Weights. Organ weights averaged across treatments (due to no treatment 
effect in most), as presented in Table 3, were obtained in order to carry out various 
calculations. Some significant increases (p<0.05) were found, such as1 3.59% increase in 
the liver, 21.74% increase in the spleen, and 32.99% increase in the kidney by the TC 
1000 diet.  In these cases the treatment average of 4 replicates were used for calculations 
to account for these differences.  The remaining organs were averaged across the 4 
treatments treatments (n=16).  Nockels et al. (1976) also reported increased liver size due 
to increased intake of alpha-tocopherol.  This could also possibly account for the increase 
in spleen weight, although spleen may only have a minor role in vitamin E metabolism 
(Hosomi et el., 1998).  Differences in the kidneys may have been due to the sampling 
error because of the difficulty in its complete tissue removal.    
Weight of organs is very specific to breed, size of the chicken, and sampling 
procedure which makes comparison to literature values difficult.  Ciftci et al. (2003) 
studied various organ weights of Babcock B-380 pullets and had similar organ weights 
74 
 
 
 
for the pancreas and digestive tract, lower weights for heart and liver, and higher weights 
for the gizzard than that found in this study.  Similar weights for the liver and spleen were 
reported by Brake and Thaxton (1979).   
Moisture Content. The average moisture contents across treatments for all organs 
(except for manure and blood) are presented in Table 3.  Significant differences were 
found in the moisture content of oviduct and fat pad (TC 1000 was higher), but these 
random differences are believed to be due to sample handling and not due to the 
treatments.  If the oviduct was not emptied or lost some free fluid during sampling, this 
could change the moisture content.  The difference in stage of the laying cycle in each 
hen may have impacted moisture content, because of the daily rhythmic water and 
mineral transfer in the oviduct during the egg laying process (Scanes et al., 2004).  No 
other organs were found to have significantly different moisture contents among any of 
the treatments.  Ruff et al. (1981) reported similar moisture contents for thigh, breast, and 
liver, but higher moisture content for the heart.  This could be due to species differences 
(broiler verse laying hen), and that our hearts had the outer fat left on.   
Lipid Content. No significant differences were found in lipid contents (dry-basis) 
of the organs across treatments, so Table 3 presents average values across treatments. The 
feed supplements were not expected to change the lipid content.  Garlich et al. (1975) 
reported the range for lipid content in the liver to be 25.8-49.0% (on a dry basis), and the 
value determined in this study (31.50%) falls in this range.  Even though the liver became 
heavier because of supplementation, its lipid content did not change.    
Tres et al. (2012) reported that lipid content in dark meat of chicken was 10.8%, 
but higher thigh fat content was found (13.28%) in this study.  The lipid content of the 
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heart was unexpectedly high (50.50%), and a possible reason was that the fat tightly 
surrounding the heart was not removed.  Ruff et al. (1981) reported a much lower amount 
of lipid (17.5%) in the heart than in this study.   
Fatty Acid Composition.  The fatty acid composition for various organ and tissue 
samples is shown in Table 4.  No significant differences were found in any fatty acids in 
any tissue except for fat pad, oviduct, brain, and manure due to treatments.  Forming and 
laid yolks had similar fatty acid profiles. The liver had higher percent composition of 
saturated fatty acids (16:0 and 18:0) and 20:4 than other organs and tissues.  Breast and 
thigh samples did not show similar fatty acid composition, possibly due to different levels 
of muscle activity creating different energy needs in these muscles.  The breast compared 
to the thigh contains much higher saturated fatty acids, and the thigh had 20:1 while the 
breast did not.  Many of the fatty acids detected in the manure are typical of that found in 
the base diet (Table 1). 
Significant differences were found across treatments in the fat pad (18:1), oviduct 
(20:5 and 22:6), brain (22:6), and manure (16:0, 18:0, 18:1, and 18:3).  The fat pad fatty 
acid composition differences could be attributed to uneven sampling.  The brain also had 
high levels of saturated fatty acids (especially 18:0).  It had very different fatty acid 
profiles compared with other organs and tissues.  The oviduct and brain were high in 20:5 
(EPA) and 22:6 (DHA) and these significantly increased with vitamin E 
supplementation.  The brain also seemed to increase in 20:4 (ARA) although not 
significant.  The T3 2000 and TC 1000 led to significantly more 22:6 than in the control 
for the brain, indicating that annatto T3s played a role in this increase of polyunsaturated 
fatty acids.   
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Surai et al (2000) found higher saturated fatty acids (16:0 and 18:0) in the liver in 
male chickens fed diets supplemented with vitamin E, with 16:0 increasing significantly 
with vitamin E supplementation.  Similarly in this study, the liver had higher percent 
saturated fatty acids (16:0 and 18:0) but no significant changes by treatments.  Also, the 
amount of 20:4 was similar between this study and ours.  The liver has a central role in 
fatty acid synthesis and lipid processing in the body producing high amounts of 16:0 and 
18:0 for the body (Berg et al, 2012).  In the heart, muscles (breast and thigh), and fat pad 
the fatty acid profiles are similar to Surai et al. (2000) but the proportions vary.  One 
factor that could impact these is gender of the chicken.  Surai et al. (2000) studied male 
chickens and this study was on laying hens.   
Our study shows similar major fatty acids (16:0, 18:1, and 18:2) in meat (thigh 
and breast) as reported in literature (Ponte et al., 2008; Tres et al., 2012; and Mourao et 
al., 2008).  Tres et al. (2012) also reported similar major fatty acids in the liver.   
Vitamin E Content and Mass Distribution  
Overall, the main organs that accumulated the supplemented vitamin E (alpha-
tocopherol, gamma-T3, and delta-T3) were the fat pad, liver and gall bladder, oviduct, 
forming yolks, laid yolks, kidney, brain, thigh, and breast (Table 5, concentration based 
on dry tissue; Table 6, concentration based on lipid).  Much of the annatto supplement 
(gamma-T3 and delta-T3) was detected in the manure indicating it was excreted by the 
laying hens.  Some organs and tissues that accumulated the supplement play a role 
vitamin E metabolism, especially the liver, kidney, and brain which have detectable 
amounts of the alpha-tocopherol transfer protein (Hosomi et el., 1998).   
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Laying hens are efficient in transferring fat soluble nutrients to the yolks as shown 
by many previous studies (Yao et al., 2013; Walker et al., 2012; and Walde et al., 2013), 
and this was also shown in this study in both the forming yolks and laid yolks.  The 
organs and tissues that accumulate and use vitamin E had different mass distribution 
depending on supplementation (Figure 1-3).   
 Alpha-tocopherol. Significantly more alpha-tocopherol was found in the highest 
supplementation diet (TC 1000) for fat pad, liver, oviduct, kidney, breast, and manure 
based on dry tissue weight (Table 5).  The forming yolk, laid yolk, and brain concentrated 
stepwise with significantly more alpha-tocopherol in TC 200 than in the control or T3 
2000 diets, and even higher yet in the TC 1000 treatment based on dry tissue (Table 5).  
When comparing the TC 1000 diet to TC 200 (5 times more alpha-tocopherol 
supplemented), interestingly, the liver, oviduct, kidney, and manure had responses that 
were greater than 5 times in concentration.  Whereas in the fat pad, forming yolk, laid 
yolk, brain, and breast, the response was less than 5 times.  Similar trends were seen 
when comparing the concentrations of alpha-tocopherol based on lipids (Table 6).    
 Some of the organs and tissues were resistant to change in alpha-tocopherol upon 
supplementation of feed.  The heart was expected to have a change as a result of the 
increased amount of the alpha-tocopherol circulating in the body, especially when blood 
is transporting the nutrients.  Although vitamin E was not quantified in the blood, it 
would increase with supplementation, as seen by Traber at el. (1992).  However, no 
increase in vitamin E was seen in the heart in this study.     
 The liver of chickens has been well studied for the amount of vitamin E because it 
plays a vital role in the uptake and selectivity of vitamin E forms.  Alpha-tocopherol 
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content in the liver was increased disproportionally; a 5-fold increase in the feed 
concentration resulted in a more than proportional amount in the liver.  A similar trend of 
vitamin E concentration in liver was reported by Tengerdy et al. (1977), as well as an 
increase in the concentration of vitamin E in the spleen, which was not observed here.  
Surai et al. (2000) carried out a feeding study with vitamin E on male broilers.  Similar 
increases of alpha-tocopherol in the liver, kidney, meat, and brain were observed.  In 
addition, increases were also seen in the heart, lungs, pancreas, and fat (Surai et al., 2000) 
that were not observed in this study.   
 The mass distribution of alpha-tocopherol (Figure 1) changed with 
supplementation, and most of the supplemented alpha-tocopherol (>70% on average) 
went to the forming yolks.  This fat soluble nutrient’s ability to accumulate in the yolk 
further supports that laying hen diets can effectively alter the composition of the resulting 
egg yolks.  Adding alpha-tocopherol to the base diets (already containing 20 IU alpha-
tocopherol from vitamin premix) caused decreases in the percent distributed to the breast 
meat (97.05% reduction) and brain (96.92% reduction)  (Figure 1).    
 Gamma-tocotrienol. Significantly more gamma T3 was detected in TC 200 and 
TC 1000 for the liver, and only in TC 1000 for the brain compared to control.  All 
treatments had significantly more gamma-T3 in breast meat compared to control based on 
dry weight.  In the forming and laid yolks, T3 2000 had significantly more gamma-T3 
than the control, and TC 1000 had significantly less gamma-T3 than the T3 2000 diet 
indicating that the presence of alpha-tocopherol at high concentrations decreased the 
transfer of gamma-T3.  This is also seen in the mass distribution (Figure 2).  This trend in 
the forming yolks was less pronounced when concentration of gamma-T3 was based on 
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lipid (Table 6), with only the control being significantly lower.  Overall, alpha-tocopherol 
impacted the transfer of gamma-T3 to tissues and organs differently; it helped transfer to 
liver, kidney, and brain, hindered transfer to laid and forming yolks, and had no effect on 
transfer to breast.  Interestingly, the organs that alpha-tocopherol helped were the organs 
found to have detectable amounts of the alpha-tocopherol transfer protein (Hosomi et al., 
1998).   
 Delta-tocotrienol. A significant increase of delta-T3 in fat pad, liver, oviduct, 
forming and laid yolks, brain, thigh meat, and breast meat was observed.  Unlike gamma-
T3, delta-T3 transfer was not impacted by the presence of alpha-tocopherol, with no 
significant differences between T3 2000 and TC 1000 (Table 5 and Table 6).  Significant 
differences among treatments were not consistent based on dry tissue and lipid. T3 2000 
was not always significantly higher than control but with added alpha-tocopherol (TC 
200 and or TC 1000 depending on tissue), a significant increase was seen.  This suggests 
that the presence of alpha-tocopherol may have assisted the uptake of delta-T3 in some 
tissues.  
Concentration of delta and gamma-T3 was not uniform in all tissues.  The fat pad, 
oviduct, and thigh accumulated significant amounts of delta-T3 but not of the gamma 
form.  Organs and tissues seem to have preferences for certain forms of vitamin E.  Also, 
accumulation of fat soluble nutrient did not always occur in the tissues predicted (i.e. 
higher fat tissues, such as skin, heart, and fat pad).  In these tissues there is a need for 
these nutrients due to their anti-oxidation potential.  This trend was also seen when 
comparing the breast and thigh meat, with the higher fat content in the thigh (13.28 %) 
than breast (8.54%) but lower vitamin E concentration.  Both the gizzard and digestive 
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tract were emptied of feed and any substance in them, but it should be noted that 
increases in these tissues may have been due to residual supplements in the feed.  If any 
feed remained in a tissue sample (i.e. gizzard or digestive tract) this would largely skew 
the quantification.      
Liver and kidney had significantly more gamma-T3 when alpha-tocopherol was 
added, and this is the opposite of what is reported in literature.  Alpha-tocopherol is 
believed to attenuate the uptake of various forms of T3s (Ikeda et al., 2003), but in this 
study it seemed to facilitate the uptake.                     
Liver had significantly more of all of the forms of vitamin E. It is not surprising 
with its central role in the uptake and bioaccumulation of the vitamin E.  However, just 
because a form of vitamin E was detected in the liver does not indicate it was distributed 
to other tissues in the body.  The liver discriminates among the various forms, 
preferentially choosing alpha-tocopherol to be distributed to other tissues while most of 
the other forms usually are excreted (National Academy of Sciences, 2000 and Traber et 
al., 1999).  This was verified with large amounts of T3s detected in the manure.     
The oviduct also had increases in the concentration of the vitamin E nutrients, 
possibly stabilizing the fatty acids that are liable to oxidation.  In the oviduct, significant 
increases in longer chain polyunsaturated fatty acids (20:4 and 22:6) were observed.    
It is evident that alpha-tocopherol is distributed to the laying hen’s body much 
better than the annatto T3s, as shown by the higher amounts quantified in various organs.  
Surai et al. (1998) reported that alpha-tocopherol was the main form of vitamin E (79-
90%) in the brain, heart, lung, and adipose tissue in young chicks, supporting high 
biodiscrimination against other forms.  All our treatment diets had 2000 ppm annatto in 
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feed but over 90% of intake was excreted in the manure.  The manure data was not 
included in the mass distribution calculation shown in Figures 1-3, so it would not 
heavily skew the distribution.    
Increasing the concentration of vitamin E throughout the laying hen body by 
supplementing feed makes it possible to increase the amount of antioxidants in the meat.  
This could have economic, quality, and nutritional impacts of the chicken meat.  
Increased amount of vitamin E has been shown to significantly decrease the formation of 
oxidation products in chicken meat during storage (Brenes et al., 2008) and reduce 
oxidative stress in tissues (Gao et al., 2010).  More work needs to be done to determine 
the oxidative stability of the breast and thigh meat in these laying hens or broilers to 
make further conclusive statements.   
It is believed to be economically feasible to increase levels of alpha-tocopherol in 
the laying hen body by increasing the concentration in the feed.  This is estimated to 
increase the cost of a dozen of eggs by approximately 10 to 15 cents.   
Cholesterol Quantification 
Blood Cholesterol. No significant differences were found in any blood lipid 
measurements across the treatments, with large natural variation in individual hens.  
Measurements of blood samples were 139.4-183.8 mg/dL total cholesterol, 13.9-18.3 
mg/dL HDL cholesterol, and 3249.4-4447.5 mg/dL TAGs.  Variances were very large 
across replicates in the same treatments.  Many studies have shown decreased cholesterol 
concentration and improvements in the blood lipid profiles by T3 supplementation 
(Qureshi et al., 1996; Qureshi et al., 2001; Pearce et al., 1992; and Yu et al., 2006), but 
we did not.   
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Qureshi et al. (1996) fed 6-week-old female chickens amaranth which showed 
reductions in the total serum cholesterol (10-30%) and LDL cholesterol (7-70%), 
minimal effect to HDL cholesterol, higher activity (10-18%) of 7-alpha-hydroxylase 
(responsible for converting cholesterol to bile salts,) and lower activity (~9%) of 3-
hydroxy-menthyglutaryl coenzyme A reductase (rate limiting enzyme in cholesterol 
synthesis).  It was suggested that such drastic improvements in cholesterol profiles may 
have been attributed to the presence of other substances in amaranth to enhance or mimic 
the effects of T3s.  Qureshi et al. (2001) also showed that T3s from rice bran suppressed 
cholesterol synthesis and improved blood lipid chemistry in 4-month-old swine by 
lowering total serum cholesterol by 32-38% and LDL cholesterol by 35-43%.   
Yu et al.
 
(2006) showed that supplementing of 50-2000 ppm of delta and gamma-
T3s (similar to this study) to 5-week old laying hens caused decreases in total serum 
cholesterol (32%), LDL level (66%), and TAGs, with minimal changes to HDL 
cholesterol.  However, such trends were not seen in this study.  Overall, many of the 
papers published in this area have used younger animal models.      
In some of the previous studies (Qureshi et al., 1996), deprivation and re-feeding 
regimens were used just prior to euthanization.  This was done to induce enzyme 
activities and to clear chylomicrons and VLDL from blood serum samples.  In this study 
this protocol was not followed which could lead to differences observed among studies.         
Organ Cholesterol. Larger variances in cholesterol concentration were observed.  
The cholesterol kit method used in this study was compared to the AOCS saponification 
and GC method (Ca 6b-53) as explained in detail in Hansen et al. (2014).  It is noted that 
the kit used in reported 18.37-20.63% more cholesterol than the saponification and GC 
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method on egg yolks, due to its quantification of all cholesterol forms, free and the 
esterified.   
No significant differences were found in cholesterol across treatments in any of 
the organs except the heart using the cholesterol kit method.  The highest amount of 
cholesterol was found in the egg yolks (14.19 mg/g yolks as-is averaged across 
treatments). The yolk has more than double of the cholesterol content in the heart and it 
was magnitudes greater than in other organs and tissues (breast, thigh, liver and gall 
bladder, kidney, and oviduct).   Literature has shown that T3s could lower the amount of 
cholesterol made by the liver (Parker et al., 1993), but we did not observe such change.  
The brain was another organ that would have been analyzed for cholesterol with its 
natural high amounts, but low sample quantity did not allow for this.      
Based on tissue as-is, T3 2000 treatment led to significantly less cholesterol in the 
heart than the control, even though the heart had no significant change in the 
concentration of T3s.  Cholesterol is synthesized in the liver and packaged into 
lipoproteins and then distributed to the rest of the body through the vascular system.  The 
liver however, did have significant increases in the amount of T3s but no significant 
changes in cholesterol.  Surprisingly, the cholesterol reducing ability of the T3s was not 
seen in the liver but was observed in the heart. When the lipid and moisture percent for 
each treatment was used to convert the cholesterol concentration from an as-is basis to a 
dry-basis and lipid basis, the decreasing cholesterol trend based as-is is lost, making the 
TC 1000 treatment having the lowest cholesterol concentration.  This suggests that alpha-
tocopherol also has cholesterol lowering ability in the heart tissue.   
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The function and health of the heart is vastly impacted by the level of cholesterol 
and lipid present, shown by a correlation between the level of cholesterol and incidence 
of cardiovascular disease (Martirosyan et al., 2007). Therefore, it is beneficial to reduce 
its cholesterol content by vitamin E supplementation.   
Beyer et al. (1993) observed similar trends and amounts in blood and tissue 
cholesterol (in breast and thigh meat).  T3s were supplemented to laying hen feed at 20 or 
200 ppm, and they did not change the amount of cholesterol in the tissue or blood 
samples significantly.  It is also interesting to compare cholesterol content as affected by 
the age of the laying hens.  Yu et al. (2006) observed significant differences in 
cholesterol content in 5-week old hens, which was similar to Qureshi et al. (1996)’s 6-
week-old female chickens when supplemented with T3s.  Whereas, in Beyer et al. (1993) 
and in this study where 48-week and 30-week old laying hens were used, respectively, no 
effects were observed.  Many factors impact function of a biological system, and age of 
the laying hens seems to be an important factor in observing the effects of T3s on 
cholesterol reduction.  As a laying hen ages, the ways vitamin E is used or functions 
could change.  With the various forms of vitamin E serving as strong antioxidants, 
especially T3s, there may be an increased need to reduce oxidative stress in the body or 
to protect the forming yolk.  
Conclusions 
    Minimal changes occurred in the organ composition (moisture, lipid, fatty acid, and 
cholesterol) due to supplementation of laying hen feed with alpha-tocopherol and annatto 
T3s (gamma and delta T3).  In some tissues (brain and oviduct), a significant increase in 
polyunsaturated fatty acids was seen with increased supplementation.  Overall, the main 
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organs that accumulated alpha-tocopherol, gamma-T3, and delta-T3 were fat pad, liver 
and gall bladder, oviduct, forming yolks, laid yolks, kidney, brain, thigh, and breast.  
Much more alpha-tocopherol is transferred into the hen’s body from the feed than the 
annatto T3s.  Alpha-tocopherol only significantly decreased the transfer of gamma-T3 to 
the laid and forming eggs, but this trend was not seen in delta-T3.   Cholesterol content 
was not significantly impacted in most tissues (breast, thigh, liver and gall bladder, 
kidney, and oviduct) except the hear.
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Tables and Figures 
 
Table 1. Composition of base diet fed to laying hens for 7 weeks 
 
Ingredient                                                                                                                      Amount (%) 
Corn 61.00 
Soybean meal 24.43 
Calcium carbonate (coarse) 5.84 
Calcium carbonate (fine) 3.90 
Dicalcium phosphate 2.02 
Animal rendered oil 1.57 
Vitamin and trace mineral premix 
a
 0.68 
Sodium chloride 0.38 
DL-methionine 0.18 
Calculated Composition % 
Crude protein 16.05 
Metabolizable energy (kcal/kg) 2,825 
Crude fat 3.94 
Linoleic acid 1.82 
Calcium 4.20 
Phosphorus (nonphytate) 0.48 
Sodium chloride 0.18 
Chloride 0.26 
Lysine (digestible) 0.77 
Methionine (digestible) 0.41 
Methionine + cysteine (digestible) 0.63 
a
 Premix includes (per kilogram of diet): vitamin A, 9000 IU; vitamin D3, 3000 IU; 
vitamin E, 20 IU; cobalamine, 13 μg; riboflavin, 6 mg; niacin, 45 mg; pantothenic acid, 
12 mg; choline, 487 mg; menadione, 1.2 mg; folic acid, 1.5 mg; pyridoxine, 1.2 mg; 
thiamine, 1.5 mg; biotin, 45 μg; magnesium, 136 mg; manganese, 136 mg; zinc, 136 mg; 
iron, 140 mg; copper, 14 mg; and selenium, 0.27 mg. 
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Table 2. Concentration of annatto tocotrienols (T3) and alpha-tocopherol (TC) in 
supplemented diets  
 
Diet Annatto 
a
 (ppm) Alpha-Tocopherol 
b
 (TC, ppm) 
Control 0 0 
T3 2000 2000 0 
TC 200 2000 200 
TC 1000 2000 1000 
a
 DeltaGold® 70 Annatto Tocotrienols: total tocotrienols, 74.5% (delta-tocotrienol 
89.2%, gamma-tocotrienol 10.8%, and other tocotrienols/tocopherols <1%). 
b
ADM 
Alpha-Tocopherol: alpha-tocopherol, 96.6%. 
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Table 3. Content of moisture and lipid, and weight for various organ, tissues, and 
manure of hens fed diets supplemented with different levels of annatto tocotrienols 
(T3) and alpha-tocopherol (TC) (n=16) 
a 
 
Organ 
 
Moisture content 
(%) 
 
Lipid  
(%, db) 
 
Organ weight  
(g) 
 
Skin 27.6 ± 3.3 71.2 ± 1.5 99.7 ± 8.7 
Fat Pad 6.5 ± 1.4 
b
 78.2 ± 2.2 40.6 ± 6.1 
Liver and gall bladder 73.6 ± 2.4 31.5 ± 4.5 57.2 ± 2.8 
b
 
Heart 68.5 ± 4.9 50.5 ± 2.9 11.1 ± 0.9 
Oviduct 78.2 ± 0.7 
b
 16.8 ± 1.3 192.1 ± 7.1 
Forming yolks 53.2 ± 1.2 61.9 ± 0.9 43.1 ± 2.2 
Laid yolks 48.5 ± 0.5 64.2 ± 0.9 14.6 ± 0.3 
Lungs (pair) 76.1 ± 2.8 29.8 ± 3.4 29.6 ± 0.1 
Spleen 72.0 ± 3.7 41.3 ± 7.0 1.6 ± 0.1 
b
 
Kidney (pair) 76.6 ± 2.5 40.7 ± 2.9 41.8 ± 3.7 
b
 
Pancreas 67.6 ± 2.8 43.8 ± 4.6 3.2 ± 0.3 
Gizzard 67.7 ± 3.7 37.4 ± 8.4 19.9 ±1.5 
Digestive tract 62.6 ± 3.3 74.8 ± 8.0 182.0 ± 10.2 
Brain 74.6 ± 1.5 43.9 ± 2.8 8.0 ± 0.7 
Thigh (both) 73.7 ± 0.9 13.3 ± 2.0 119.1 ± 7.3 
Breast (both) 71.0 ± 0.4 8.5 ± 0.5 76.9 ± 7.3 
Manure 
c
 -       4.9 ± 0.7      -  
a 
Values are means ± standard deviations across 4 treatments with 4 replicates for each. 
b 
Significant differences were found in these samples among the 4 treatments.  
c 
75% and 120 
grams/day were used as estimates of the manure moisture and weight, respectively.  
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Table 4. Fatty acid composition (%) in various organ and tissue samples and manure for hens fed diets supplemented with 
different levels of annatto tocotrienols (T3) and alpha-tocopherol (TC) (n=4) 
a 
 
Control (%) 
14:0 
 
16:0 
 
16:1 
 
18:0 
 
18:1 
 
18:2 
 
18:3 
 
20:1 
 
20:4 (ARA) 
 
20:5 (EPA) 
 
 
22:6 (DHA) 
 
Skin - 19.1 ± 0.9 2.1 ± 0.2 6.9 ± 0.5 38.0 ± 1.1 30.1 ± 2.1 1.3 ± 0.1 - - - - 
Fat pad* - 15.9 ± 2.3  1.7 ± 0.3  6.2 ± 0.7 32.0 ± 2.8 B 26.5 ± 2.6 1.1 ± 0.2 - - - - 
Liver  - 25.4 ± 0.9 1.9 ± 0.2 12.0 ± 1.0 35.5 ± 2.0 17.7 ± 2.7 - - 3.3 ± 0.7 - - 
Heart 0.5 ± 0.1 20.3 ± 0.4 2.6 ± 0.3 7.7 ± 0.2 35.6 ± 3.1 27.5 ± 1.4 1.1 ± 0.2 - 0.4 ± 0.4 - - 
Oviduct* - 24.0 ± 1.5 1.9 ± 0.5 8.3 ± 1.7 29.3 ± 0.6 22.3 ± 3.5 1.2 ± 0.1 - 0.9 ± 0.2 6.7 ± 0.9 A,B 1.9 ± 0.3 B 
Forming yolk  - 25.6 ± 0.5 2.5 ± 0.2 9.7 ± 0.8 39.7 ± 0.1 16.1 ± 0.2 - - 2.1 ± 0.2 - 0.5 ± 0.1 
Laid yolk - 24.3 ± 4.5 2.3 ± 0.2 9.7 ± 0.5 40.1 ± 1.7 16.5 ± 0.6 - - 2.1 ± 0.2 - 0.5 ± 0.1 
Lung - 25.4 ± 0.5 2.0 ± 0.1 9.0 ± 0.2 36.4 ± 0.9  21.3 ± 1.2 0.9 ± 0.1 - 1.4 ± 0.2 - - 
Spleen - 23.6 ± 1.0  1.7 ± 0.2 9.5 ± 1.1 36.0 ± 1.3 23.6 ± 0.7 0.9 ± 0.2 - 0.9 ± 0.2 - - 
Kidney - 19.6 ± 0.9 1.6 ± 0.2 9.8 ± 0.5 35.7 ± 0.5 27.6 ± 1.2 1.2 ± 0.1 - 1.0 ± 0.2 1.2 ± 0.8 - 
Pancreas - 21.8 ± 2.3 1.6 ± 0.4 9.0 ± 1.0 37.2 ± 1.2 25.6 ± 3.7 0.9 ± 1.1 
    Gizzard 0.4 ± 0.3 24.0 ± 5.4 1.9 ± 0.6 7.4 ± 4.0 36.0 ± 3.1 26.5 ± 2.1 0.8 ± 0.6 - - - - 
Digestive tract - 20.6 ± 0.8 1.8 ± 0.1 7.5 ± 0.3 37.5 ± 0.6 28.5 ± 1.4 1.2 ± 0.1 - - - 
 Brain* 1.3 ± 1.9 32.3 ± 1.8 23.0 ± 2.2 23.4 ± 3.2 13.7 ± 4.6 - - - 1.8 ± 2.5 - - B 
Thigh - 19.3 ± 0.5 1.3 ± 0.9 9.9 ± 1.0 29.1 ± 3.1 30.4 ± 1.5 0.9 ± 0.6 2.4 ± 0.4 4.9 ± 6.9 - - 
Breast  1.4 ± 1.7 25.7 ± 10.5 10.5 ± 1.1 26.9 ± 1.8 25.0 ± 1.7 5.1 ± 1.5 2.1 ± 4.1 - - - - 
Manure* - 12.4 ± 1.8 B 3.2 ± 1.83 22.9 ± 5.5 B,C 48.5 ± 6.7 A 4.0 ± 3.9 2.2 ± 1.8 A,B - - - - 
T3 2000 (%) 
 
14:0 
 
16:0 
 
16:1 
 
18:0 
 
18:1 
 
18:2 
 
18:3 
 
20:1 
 
20:4 (ARA) 
 
20:5 (EPA) 
 
22:6 (DHA) 
 
Skin - 18.7 ± 1.8 3.4 ± 2.3 6.7 ± 0.6 38.6 ± 2.9 27.5 ± 2.1 2.0 ± 2.5 - - - - 
Fat pad* - 20.2 ± 2.0  2.3 ± 0.4  7.3 ± 0.8 37.0 ± 1.1 A,B 29.2 ± 1.1 0.9 ± 0.6 - - - - 
Liver  - 26.7 ± 1.5 1.9 ± 0.3 12.7 ± 1.3 38.4 ± 2.9 15.3 ± 1.6 - - 2.1 ± 1.6 - - 
Heart 0.5 ± 0.1 20.6 ± 0.3 2.9 ± 0.2 7.5 ± 0.3 38.1 ± 0.5 26.0 ± 0.8 1.1 ± 0.1 - 0.7 ± 0.1 - - 
Oviduct* - 23.7 ± 0.4 1.4 ± 1.1 8.3 ± 0.7 30.1 ± 1.4 22.0 ± 2.0 0.9 ± 0.6 - 0.7 ± 0.5 9.0 ± 2.4 A 1.9 ± 0.7 B 
Forming yolk  - 24.7 ± 0.3 2.2 ± 0.1 10.3 ± 0.6 40.1 ± 0.6 15.9 ± 0.2 - - 2.2 ± 0.1 - 0.6 ± 0.1 
Laid yolk - 24.3 ± 4.5 2.3 ± 0.2 9.7 ± 0.5 40.1 ± 1.7 16.5 ± 0.6 - - 2.1 ± 0.2 - 0.5 ± 0.1 
Lung - 24.2 ± 1.5 1.9 ± 0.2 9.2 ± 0.7 38.2 ± 1.1  20.7 ± 0.4 0.6 ± 0.4 - 0.8 ± 0.6 - - 
Spleen - 23.3 ± 0.9  1.8 ± 0.1 9.0 ± 0.5 37.1 ± 0.8 23.4 ± 1.7 0.9 ± 0.1 - 0.8 ± 0.5 - - 
Kidney - 22.0 ± 3.1 1.8 ± 0.1 10.4 ± 2.1 37.2 ± 0.7 24.5 ± 3.1 0.8 ± 0.6 - 0.6 ± 0.4 1.0 ± 0.7 - 
Pancreas - 20.3 ± 0.7 1.8 ± 0.1 8.2 ± 0.2 38.5 ± 0.8 25.7 ± 1.2 1.1 ± 0.2 - - - - 
Gizzard 0.5 ± 0.1 21.2 ± 0.4 2.0 ± 0.1 8.0 ± 0.4 36.7 ± 0.4 26.8 ± 0.6 1.1 ± 0.1 - - - - 
Digestive tract - 20.7 ± 0.3 2.0 ± 0.1 7.7 ± 0.3 38.6 ± 0.2 27.4 ± 0.8 1.1 ± 0.1 - 
 
- - 
Brain* - 22.0 ± 6.6 16.8 ± 4.6 14.6 ± 10.7 6.8 ± 5.0 - - - 11.6 ± 12.5 5.6 ± 2.4 10.2 ± 0.7 A  
Thigh - 19.2 ± 0.5 1.7 ± 0.3 9.7 ± 0.7 30.8 ± 1.3 30.4 ± 1.3 1.1 ± 0.1 2.7 ± 0.3 1.5 ± 0.4 - - 
Breast  1.6 ± 1.7 34.4 ± 9.3 9.3 ± 6.3 25.0 ± 7.2 20.1 ± 9.9 - - - - - - 
Manure* - 20.2 ± 1.3 A 9.6 ± 1.9 37.7 ± 2.2 A,B 32.1 ± 5.9 B 0.4 ± 0.8 10.0 ± 2.0 A - - - - 
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        Table 4. cont’d   
 
 
TC 200 (%) 
 
14:0 
 
16:0 
 
16:1 
 
18:0 
 
18:1 
 
18:2 
 
18:3 
 
20:1 
 
20:4 (ARA) 
 
20:5 (EPA) 
 
22:6 (DHA) 
 
 Skin - 19.4 ± 1.2 2.3 ± 0.3 6.7 ± 0.7 38.4 ± 1.8 29.5 ± 0.9 1.2 ± 0.1 - - - - 
 Fat pad* - 18.3 ± 0.8  1.9 ± 0.2  7.1 ± 0.8 36.9 ± 3.1 A,B 27.9 ± 3.1 1.3 ± 0.2 - - - - 
 Liver  - 25.5 ± 3.6 1.9 ± 0.7 12.5 ± 0.6 37.4 ± 4.8 16.3 ± 5.3 - - 2.7 ± 2.0 - - 
 Heart 0.5 ± 0.1 20.3 ± 1.2 2.8 ± 0.3 7.8 ± 0.3 38.1 ± 0.8 26.3 ± 0.8 1.2 ± 0.1 - 0.7 ± 0.1 - - 
 Oviduct* - 23.6 ± 1.3 1.7 ± 0.3 8.5 ± 0.7 29.5 ± 2.1 21.0 ± 1.5 1.2 ± 0.2 - 0.7 ± 0.1 0.8 ± 0.6 B 8.3 ± 1.4 A 
 Forming yolk  - 24.9 ± 0.9 2.2 ± 0.2 9.8 ± 0.7 40.7 ± 0.7 15.9 ± 0.6 - - 2.2 ± 0.2 - 0.6 ± 0.1 
 Laid yolk - 24.3 ± 4.5 2.3 ± 0.2 9.7 ± 0.5 40.1 ± 1.7 16.5 ± 0.6 - - 2.1 ± 0.2 - 0.5 ± 0.1 
 Lung - 24.4 ± 0.5 1.9 ± 0.2 9.2 ± 0.3 37.3 ± 0.7  20.6 ± 0.8 0.7 ± 0.5 - 1.4 ± 0.4 - - 
 Spleen - 22.6 ± 1.7  1.7 ± 0.2 9.1 ± 0.6 37.6 ± 0.8 24.1 ± 1.6 1.0 ± 0.1 - 0.8 ± 0.4 - - 
 Kidney - 22.8 ± 4.2 2.0 ± 0.4 6.9 ± 4.6 37.7 ± 1.3 27.6 ± 2.1 0.6 ± 0.7 
 
0.4 ± 0.4 0.6 ± 0.7 - 
 Pancreas - 21.6 ± 1.5 1.7 ± 0.3 8.9 ± 0.4 36.8 ± 2.2 25.0 ± 2.4 1.0 ± 0.1 - - - - 
 Gizzard 0.3 ± 0.2 22.3 ± 4.5 2.0 ± 0.3 6.3 ± 2.2 37.3 ± 0.6 27.9 ± 1.2 0.6 ± 0.4 - - - - 
 Digestive tract - 20.6 ± 0.7 1.9 ± 0.1 7.8 ± 0.2 38.5 ± 0.7 27.6 ± 0.4 1.1 ± 0.1 - - - - 
 Brain* 2.1 ± 2.6 25.2 ± 3.6 19.2  ± 1.5 22.8 ± 1.5 10.8 ± 1.8 - - - 0.9 ± 0.8 5.6 ± 5.6 5.7 ± 4.4 A,B  
 Thigh - 19.0 ± 0.6 1.6 ± 0.2 9.8 ± 0.5 30.9 ± 1.2 29.9 ± 1.8 1.1 ± 0.1 2.6 ± 0.5 3.1 ± 3.0 - - 
 Breast  - 30.3 ± 11.9 11.9 ± 2.0 23.0 ± 9.3 23.5 ± 4.6 5.7 ± 5.7 2.2 ± 3.5 - - - - 
 
Manure* - 21.6 ± 3.4 A 5.88 ± 7.07 44.1 ± 4.6 A 
55.1 ± 11.3 
A,B 1.9 ± 3.8 - B - - - - 
 
TC 1000 (%) 
 
14:0 
 
16:0 
 
16:1 
 
18:0 
 
18:1 
 
18:2 
 
18:3 
 
20:1 
 
20:4 (ARA) 
 
20:5 (EPA) 
 
22:6 (DHA) 
 
 Skin - 20.0 ± 0.7 2.4 ± 0.2 6.8 ± 0.3 39.3 ± 1.8 28.3 ± 0.9 1.2 ± 0.1 - - - - 
 Fat pad* - 18.6 ± 0.7  1.9 ± 0.2  7.6 ± 0.2 39.7 ± 1.4 A 30.0 ± 1.0 1.4 ± 0.1 - - - - 
 Liver  - 24.7 ± 0.6 1.9 ± 0.2 11.9 ± 0.5 39.0 ± 1.7 16.3 ± 1.2 - - 2.6 ± 0.5 - - 
 Heart 0.5 ± 0.1 20.2 ± 0.9 2.8 ± 0.2 7.5 ± 0.1 38.0 ± 1.3 26.6 ± 0.9 1.1 ± 0.1 - 0.7 ± 0.1 - - 
 Oviduct* - 24.0 ± 1.6 1.4 ± 1.0 7.8 ± 0.8 29.0 ± 0.8 23.7 ± 2.6 0.9 ± 0.6 - 0.7 ± 0.6 7.8 ± 4.7 A,B 3.2 ± 3.5 A, B 
 Forming yolk  - 24.8 ± 0.6 2.2 ± 0.1 10.0 ± 0.7 40.6 ± 0.7 15.5 ± 0.8 - - 2.1 ± 0.1 - 0.5 ± 0.1 
 Laid yolk - 24.3 ± 4.5 2.3 ± 0.2 9.7 ± 0.5 40.1 ± 1.7 16.5 ± 0.6 - - 2.1 ± 0.2 - 0.5 ± 0.1 
 Lung - 24.8 ± 0.7 2.2 ± 0.2 9.9 ± 0.3 40.4 ± 0.4 15.9 ± 0.3 - - 2.2 ± 0.2 0.6 ± 0.1 - 
 Spleen - 21.2 ± 0.4  1.6 ± 0.2 8.9 ±  0.5 37.1 ± 2.1 26.4 ± 2.0 1.1 ± 0.1 - 1.2 ± 0.4 - - 
 Kidney - 21.0 ± 0.7 1.7 ± 0.3 10.4 ± 1.0 37.8 ± 1.5 26.7 ± 0.9 0.7 ± 0.5 - 0.3 ± 0.6 0.5 ± 0.9 - 
 Pancreas - 22.3 ± 1.7 1.3 ± 0.8 8.5 ± 0.7 37.2 ± 3.4 27.1 ± 1.9 0.7 ± 0.5 - - - - 
 Gizzard 0.4 ± 0.3 21.6 ± 0.9 2.0 ± 0.2 7.8 ± 0.3 35.8 ± 1.4 28.5 ± 2.0 0.8 ± 0.3 - - - - 
 Digestive tract - 20.5 ± 0.4 1.8 ± 0.2 7.9 ± 0.2 37.7 ± 1.8 28.9 ± 1.6 1.2 ± 0.1 - - - - 
 Brain* - 30.4 ± 1.0 20.5 ± 1.0 12.6 ± 0.9 12.6 ± 0.9 - - - 0.2 ± 0.5 - 11.4 ± 0.2 A  
 Thigh - 19.3 ± 0.5 1.7 ± 0.1 10.0 ± 0.6 31.4 ± 0.9 28.8 ± 1.8 1.1 ± 0.1 2.7 ± 0.5 3.4 ± 2.9 - - 
 Breast  1.7 ± 2.0 27.8 ± 5.8 5.8 ± 5.8 24.4 ± 3.9 33.7 ± 8.0 0.7 ± 1.3 - - - - - 
 Manure* 
 
18.2 ± 3.0 A,B 1.7 ± 2.2 16.4 ± 8.2 C 55.1 ± 11.7 A 5.3 ± 6.7 2.8 ± 5.5 A,B - - - - 
 a Values are means ± standard deviations.  b Diets detailed in Table 2, T3 = ppm annatto, TC = ppm alpha-tocopherol with constant 2000 ppm annatto. 
c 
Different letters 
(comparing all treatments) with in the same organ or tissue indicate significant differences at the 99% confidence level. *p-value = 0.01, NS not significant at 1%. – indicates not 
detected.  ARA = arachidonic acid, EPA = eicosapentaenoic acid, DHA = docosahexaenoic 
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Table 5. Concentration (ppm based on dry organ) of alpha-tocopherol, gamma-tocotrienol, and delta-tocotrienol in various organs and 
tissues and manure from hens fed diets supplemented with different levels of annatto tocotrienols (T3) and alpha-tocopherol (TC) (n=4) 
a 
Alpha-tocopherol (ppm based on dry organ) 
 
Control
b
 T3 2000
b
 TC 200
b
 TC 1000
b
 Significance
c
 
 Skin - - - - - 
Fat pad 0.01 ± 0.02 B 0.02 ± 0.02 B 0.08 ± 0.07 B 0.27 ± 0.03 A * 
Liver and gall bladder 0.06 ± 0.07 B 0.18 ± 0.08 B 31.89 ± 36.51 B 187.71 ± 36.77 A * 
Heart 0.05 ± 0.09 - 0.03 ± 0.05 0.01 ± 0.02 NS 
Oviduct 0.47 ± 0.86 B 0.02 ± 0.03 B 2.98 ± 5.11 B 34.18 ± 16.80 A * 
Forming yolk  2.59 ± 2.01 C 3.18 ± 1.83 C 302.48 ± 9.45 B 1154.41 ± 63.97 A * 
Laid yolks 58.30 ± 12.78 C 68.42 ± 7.32 C 694.98 ± 9.42 B 2570.80 ± 189.92 A * 
Lung 0.02 ± 0.03 0.01 ± 0.01 - 0.08 ± 0.07 NS 
Spleen 0.09 ± 0.03 0.13 ± 0.03 0.11 ± 0.05 0.19 ± 0.08 NS 
Kidney 0.11 ± 0.06 B 0.15 ± 0.04 B 2.73 ± 5.08 B 21.90 ± 9.72 A * 
Pancreas 0.08 ± 0.02 0.05 ± 0.01 0.08 ± 0.02 0.08 ± 0.06 NS 
Gizzard 0.01 ± 0.01 0.01 ± 0.02 0.02 ± 0.03 0.02 ± 0.04 NS 
Digestive tract - - 0.30 ± 0.60 3.09 ± 5.25 NS 
Brain 2.40 ± 0.53 C 2.04 ± 0.70 C 5.78 ± 0.40 B 12.75 ± 2.21 A * 
Thigh 0.06 ± 0.01 0.05 ± 0.01 0.52 ± 0.87 8.82 ± 8.98 NS 
Breast 0.87 ± 0.17 B 1.13 ± 0.11 B 2.05 ± 0.42 B 6.97 ± 1.41 A * 
Manure 3.68 ± 1.19 B 21.14 ± 19.24 B 98.82 ± 18.41 B 504.98 ± 96.37 A * 
Gamma-tocotrienol (ppm based on dry organ) 
 
Control
b
 T3 2000
b
 TC 200
b
 TC 1000
b
 Significance
c
 
Skin 0.03 ± 0.02 0.06 ± 0.06 0.02 ± 0.02 0.03 ± 0.04 NS 
Fat pad 0.02 ± 0.02 0.02 ± 0.03 0.03 ± 0.04 0.15 ± 0.24 NS 
Liver and gall bladder - B 0.01 ± 0.03 B 0.58 ± 0.30 A 0.68 ± 0.14 A * 
Heart - 0.01 ± 0.02 - - NS 
Oviduct 0.01 ± 0.01 0.15 ± 0.15 0.24 ± 0.21 0.25 ± 0.05 NS 
Forming yolk  0.07 ± 0.04 C 1.38 ± 0.24 A 1.08 ± 0.14 A,B 1.03 ± 0.16 B * 
Laid yolks 0.42 ± 0.02 C 12.12 ± 1.90 A 10.12 ± 0.98 A,B 9.24 ± 0.72 B * 
Lung 0.01 ± 0.02 - - - NS 
Spleen - - - - NS 
Kidney 0.01 ± 0.02 B 0.03 ± 0.02 B 0.18 ± 0.22 B 0.55 ± 0.12 A * 
Pancreas - - - - NS 
Gizzard - - - 0.01 ± 0.01 NS 
Digestive tract 0.02 ± 0.02 0.03 ± 0.02 0.16 ± 0.26 0.63 ± 0.85 NS 
Brain - B 0.12 ± 0.04 B 0.14 ± 0.03 B 0.15 ± 0.06 A * 
Thigh - 0.19 ± 0.15 0.24 ± 0.09 0.24 ± 0.17 NS 
Breast 0.02 ± 0.04 B 0.25 ± 0.05 A 0.22 ± 0.06 A 0.19 ± 0.02 A * 
Manure 0.63 ± 0.17 C 29.88 ± 7.90 A 18.41 ± 4.70 B 25.77 ± 5.27 A,B * 
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Table 5. cont’d 
 
Delta-tocotrienol (ppm based on dry organ) 
 
Control
b
 T3 2000
b
 TC 200
b
 TC 1000
b
 Significance
c
 
Skin 0.02 ± 0.04 0.07 ± 0.14 - 0.07 ± 0.09 NS 
Fat pad - B 0.76 ± 1.03 A,B 0.92 ± 1.03 A,B 3.08 ± 2.16 A * 
Liver and gall bladder - B 1.28 ± 1.62 A,B 2.26 ± 1.21 A 2.20 ± 0.43 A * 
Heart - - - - - 
Oviduct 0.01 ± 0.02 B 0.78 ± 0.41 A,B 1.58 ± 1.44 A,B 0.81 ± 0.07 A * 
Forming yolk  - B 2.81 ± 0.39 A 2.59 ± 0.55 A 2.26 ± 0.34 A * 
Laid yolks 0.18 ± 0.36 B 22.70 ± 3.68 A 21.38 ± 3.62 A 18.98 ± 1.12 A * 
Lung - - 0.01 ± 0.02 0.01 ± 0.01 NS 
Spleen - - - - NS 
Kidney - 2.06 ± 1.75 1.70 ± 1.24 2.26 ± 0.45 NS 
Pancreas - - 0.03 ± 0.05 0.04 ± 0.05 NS 
Gizzard 0.01 ± 0.02 0.02 ± 0.02 0.03 ± 0.06 0.02 ± 0.02 NS 
Digestive tract 0.01 ± 0.01 0.18 ± 0.10 1.67 ± 2.82 6.03 ± 8.73 NS 
Brain 0.01 ± 0.03 B 0.45 ± 0.11 A,B 0.75 ± 0.26 A 0.64 ± 0.41 A * 
Thigh 0.01 ± 0.01 B 1.00 ± 0.45 A 1.16 ± 0.32 A 1.05 ± 0.10 A * 
Breast 0.01 ± 0.01 B 0.72 ± 0.14 A,B 1.11 ± 0.94 A 0.61 ± 0.12 A,B * 
Manure 0.32 ± 0.36 B 186.99 ± 55.87 A 120.88 ± 33.67 A 156.62 ± 33.26 A * 
      
a Values are means ± standard deviations.  b Diets detailed in Table 2, T3 = ppm annatto, TC = ppm alpha-tocopherol with constant 2000 ppm annatto. c Different letters (comparing 
all treatments) in the same row indicate significant differences at the 95% confidence level. * p-value = 0.05, NS not significant at 5%. – indicates not detected.   
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Table 6. Concentration (ppm based on lipid) of alpha-tocopherol, gamma-T3, and delta-T3 in various organs and tissues and manure from 
hens fed diets supplemented with different levels of annatto tocotrienols (T3) and alpha-tocopherol (TC) (n=4) 
a 
Alpha-tocopherol (ppm based on lipid) 
Organ Control
b
 T3 2000
b
 TC 200
b
 TC 1000
b
 Significance
c
 
Skin - - - - - 
Fat pad 0.02 ± 0.03 B 0.03 ± 0.02 B 0.11 ± 0.10 B 0.40 ± 0.04 A * 
Liver and gall bladder 0.84 ± 0.97 B 1.91 ± 0.84 B 390.50 ± 477.08 B 2272.96 ± 445.27 A * 
Heart 0.28 ± 0.56 - 0.16 ± 0.32 0.09 ± 0.17 NS 
Oviduct 12.33 ± 22.77 B 0.57 ± 0.68 B 83.97 ± 143.91 B 941.50 ± 462.84 A * 
Forming yolk  8.90 ± 6.89 C 10.88 ± 6.27 C 1056.90 ± 33.02 B 3986.93 ± 220.93 A * 
Laid yolk 79.29 ± 17.38 C 93.05 ± 9.96 C 945.14 ± 12.81 B 3496.29 ± 258.29 A * 
Lung 0.22 ± 0.45 0.08 ± 0.09 0.06 ± 0.12 1.19 ± 0.97 NS 
Spleen 0.77 ± 0.28 1.24 ± 0.28 0.83 ± 0.36 1.71 ± 0.73 NS 
Kidney 1.53 ± 0.83 B 1.70 ± 0.46 B 25.13 ± 46.68 B 222.79 ± 98.86 A * 
Pancreas 0.54 ± 0.16 0.34 ± 0.06 0.58 ± 0.16 0.55 ± 0.40 NS 
Gizzard 0.08 ± 0.06 0.10 ± 0.20 0.08 ± 0.16 0.18 ± 0.37 NS 
Digestive tract - 0.01 ± 0.01 1.20 ± 2.39 11.28 ± 19.13 NS 
Brain 21.34 ± 4.45 C 18.10 ± 6.26 C 52.16 ± 3.59 B 118.31 ± 20.47 A * 
Thigh 1.84 ± 0.38 1.42 ± 0.36 14.94 ± 25.03 223.38 ± 227.44 NS 
Breast 36.39 ± 6.95 B 41.21 ± 4.18 B 83.08 ± 17.15 B 290.57 ± 58.81 A * 
Manure 303.81 ± 98.55 C 935.17 ± 52.73 B,C 9235.90 ± 1720.34 B 37199.18 ± 7098.76 C * 
 Gamma-tocotrienol (ppm based on lipid) 
 Control
b
 T3 2000
b
 TC 200
b
 TC 1000
b
 Significance
c
 
Skin 0.05 ± 0.04 0.12 ± 0.11 0.04 ± 0.05 0.06 ± 0.07 NS 
Fat pad 0.02 ± 0.02 0.02 ± 0.04 0.04 ± 0.05 0.22 ± 0.35 NS 
Liver and gall bladder - B 0.16 ± 0.31B 7.13 ± 3.64 A 8.22 ± 1.66 A * 
Heart - 0.07 ± 0.14 - - NS 
Oviduct 0.15 ± 0.30 4.15 ± 3.98 6.85 ± 5.94 6.80 ± 1.35 NS 
Forming yolk  0.22 ± 0.15 B 4.72 ± 0.83 A 3.79 ± 0.50 A 3.56 ± 0.56 A * 
Laid yolk 0.57 ± 0.03 C 16.48 ± 2.58 A 13.76 ± 1.33 A,B 12.57 ± 0.98 B * 
Lung 0.12 ± 0.23 - - - NS 
Spleen -  - - - 
Kidney 0.13 ± 0.26 B 0.29 ± 0.20 B 1.70 ± 2.03 B 5.60 ± 1.25 A * 
Pancreas 0.02 ± 0.04 - - - NS 
Gizzard - 0.03 ± 0.06 - 0.05 ± 0.11 NS 
Digestive tract 0.06 ± 0.07 0.09 ± 0.07 0.65 ± 1.05 2.30 ± 3.10 NS 
Brain - B 1.07 ± 0.38 A 1.30 ± 0.23 A 1.36 ± 0.55 A * 
Thigh 0.14 ± 0.27 5.60 ± 4.51 6.87 ± 2.54 6.12 ± 4.19 NS 
Breast 0.86 ± 1.71 B 9.21 ±1.74 A 8.85 ± 2.58 A 8.08 ± 0.93 A * 
Manure 52.41 ± 13.87 B 2424.33 ± 641.24 A 1720.33 ± 439.19 A 1898.65 ± 388.31 A * 
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Table 6. cont‘d  
Delta-tocotrienol (ppm based on lipid) 
 
Controlb T3 2000
b
 TC 200
b
 TC 1000
b
 Significance
c
 
Skin 0.04 ± 0.08 0.13 ± 0.26 - 0.14 ± 0.17 NS 
Fat pad - B 1.01 ± 1.37 A,B 1.24 ± 1.39 A,B 4.61 ± 3.24 A * 
Liver and gall bladder - B 13.77 ± 17.39 A,B 27.66 ± 14.83 A 26.66 ± 5.17 A * 
Heart - - - - NS 
Oviduct 0.25 ± 0.49 B 21.02 ± 10.89 A,B 44.61 ± 40.43 A 22.26 ± 2.06 A,B * 
Forming yolk  0.02 ± 0.03 B 9.63 ± 1.32 A 9.06 ± 1.92 A 7.80 ± 1.19 A * 
Laid yolk 0.24 ± 0.49 B 30.87 ± 5.00 A 29.08 ± 4.92 A 25.81 ± 1.52 A * 
Lung - - 0.13 ± 0.26 0.08 ± 0.17 NS 
Spleen - - - - NS 
Kidney - 23.07 ± 19.54 15.58 ± 11.43 22.98 ± 4.57 NS 
Pancreas - - 0.21 ± 0.42 0.32 ± 0.39 NS 
Gizzard 0.07 ± 0.14 0.19 ± 0.14 0.17 ± 0.34 0.19 ± 0.14 NS 
Digestive tract 0.04 ± 0.05 0.61 ± 0.35 6.70 ± 11.27 21.98 ± 31.82 NS 
Brain 0.12 ± 0.24 B 4.01 ± 0.98 A,B 6.80 ± 2.37 A 5.95 ± 3.83 A * 
Thigh 0.18 ± 0.36 B 30.08 ± 13.54 A 33.28 ± 9.11 A 26.51 ± 2.44 A * 
Breast 0.24 ± 0.49 B 26.19 ± 5.02 A,B 45.25 ± 38.06 A 25.57 ± 5.16 A,B * 
Manure 26.43 ± 29.88 B 15171.61 ± 4532.67 A 11297.54 ± 3146.42 A 11537.68 ± 2449.77 A * 
 
a 
Values are means ± standard deviations.  
b 
Diets detailed in Table 2, T3 = ppm annatto, TC = ppm alpha-tocopherol with constant 2000 ppm 
annatto. 
c 
Different letters (comparing all treatments) in the same row indicate significant differences at the 95% confidence level. * p-value = 
0.05, NS not significant at 5%.  – indicates not detected.   
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Table 7. Cholesterol content of select organs and tissues from hens fed diets supplemented with different levels of 
annatto tocotrienols (T3) and alpha-tocopherol (TC) (n=4) 
a 
 
mg Cholesterol / g organ as-is Control 
b
 T3 2000
b
 TC 200
b
 TC 1000
b
 Significance 
c
 
Breast 0.33 ± 0.05 0.37 ± 0.12 0.34 ± 0.09 0.37 ± 0.12 NS 
Thigh 0.94 ± 0.11 0.74 ± 0.09 0.75 ± 0.13  0.82 ± 0.12 NS 
Liver and gall bladder 3.56 ± 0.29 4.24 ± 0.47 3.45 ± 0.22 3.45 ± 0.24 NS 
Kidney 3.69 ± 0.57 3.88 ± 0.69 3.46 ± 0.22 3.33 ± 0.41 NS 
Oviduct 2.47 ± 0.82  2.51 ± 0.48  2.14 ± 0.23  1.82 ± 0.23  NS 
Heart 5.70 ± 0.71 A 3.64 ± 0.42 B 5.25 ± 0.42 A 4.32 ± 0.45 A,B ** 
Laid egg yolks 14.87 ± 0.49 14.46 ± 0.25 13.49 ± 0.92 13.94 ± 1.42 NS 
mg Cholesterol / g dry organ Control 
b
 T3 2000
b
 TC 200
b
 TC 1000
b
 Significance 
c
 
Breast 1.12 ± 0.16 1.27 ± 0.42 1.16 ± 0.31 1.24 ± 0.42 NS 
Thigh 3.62 ± 0.44 2.86 ± 0.36 2.85 ± 0.49  3.08 ± 0.44 NS 
Liver and gall bladder 13.70 ± 1.10 15.64 ± 1.73 13.10 ± 0.85 13.57 ± 0.96 NS 
Kidney 16.60 ± 2.57 17.23 ± 3.08 14.75 ± 0.99 14.21 ± 1.82 NS 
Oviduct 11.22 ± 0.37  11.31 ± 2.17 9.57 ± 1.01  8.75 ± 1.11 NS 
Heart 10.89 ± 1.36 A,B 11.23 ± 1.29 A 9.81 ± 1.23 A,B 7.99 ± 0.49 B ** 
Laid egg yolks 28.77 ± 1.51 28.04 ± 0.49 26.33 ± 1.79 27.25 ± 2.77 NS 
mg Cholesterol / g lipid Control 
b
 T3 2000
b
 TC 200
b
 TC 1000
b
 Significance 
c
 
Breast 13.66 ± 1.94 13.49 ± 4.45 13.73 ± 3.64 14.68 ± 5.00 NS 
Thigh 29.44 ± 3.59 22.35 ± 2.83 21.57 ± 3.72  20.80 ± 2.96 NS 
Liver and gall bladder 47.32 ± 3.81 47.18 ± 5.22 42.64 ± 2.78 40.90 ± 2.92 NS 
Kidney 42.74 ± 6.62 43.91 ± 7.86 33.18 ± 2.23 35.20 ± 4.51 NS 
Oviduct 65.09 ± 2.17  67.34 ± 12.91 60.37 ± 6.40  50.21 ± 6.39 NS 
Heart 22.67 ± 2.84 A 22.13 ± 2.55 A 19.62 ± 2.47 A,B 15.03 ± 0.92 B ** 
Laid egg yolks 44.97 ± 2.36 43.61 ± 0.75 41.34 ± 2.80 42.97 ± 4.36 NS 
a 
Values are means ± standard deviations.  
b 
Diets detailed in Table 2, T3 = ppm annatto, TC = ppm alpha-tocopherol with 
constant 2000 ppm annatto. 
C 
Different letters (comparing all treatments) in the same row indicate significant differences at 
the 99% confidence level. ** p-value = 0.01, NS not significant at 1%. – indicates not detected.   
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Figure 1. Mass distribution of alpha-tocopherol in various organs and tissues of 
laying hens. 
All diets with supplementation have 2000ppm annatto and manure was excluded. Error bars = SD. 
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Figure 2. Mass distribution of gamma-tocotrienol in various organs and tissues of 
laying hens.  
All diets with supplementation have 2000ppm annatto and manure was excluded. Error bars = SD. 
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Figure 3. Mass distribution of delta-tocotrienol in various organs and tissues of 
laying hens.  
All diets with supplementation have 2000ppm annatto and manure was excluded. Error bars = SD. 
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CHAPTER 5 
SUMMARY AND CONCLUSIONS 
In summary, annatto and alpha-tocopherol did not significantly impact most 
quality parameters analyzed of the resulting egg yolks (hen performance: laying rate and 
hen weight, physical or quality parameters; whole egg weight, egg yolk weight, eggshell 
strength, yolk color, HU, and eggshell thickness; sensory attributes: moistness, 
smoothness, chalkiness/mouth-drying, bitterness, and off-flavor; and chemical 
measurements: egg yolk total moisture, egg yolk lipid, egg yolk phospholipids, egg yolk 
fatty acids, and egg yolk cholesterol).  Significant differences were found in the daily 
feed intake, egg yolk viscosity, sensory yolk color and savory yolk flavor, and in the 
amount and transfer efficiency of the vitamin E supplements to the egg yolks.  Based on 
both the transfer efficiencies at maximum value and data over time for alpha-tocopherol, 
gamma-T3, and delta-T3, it is evident that alpha-tocopherol is much better transferred to 
hen egg yolks and does play a role in how the other forms of vitamin E are absorbed.   
 Minimal changes occurred in the organ composition (moisture, lipid, fatty acid, and 
cholesterol) due to supplementation of laying-hen feed with alpha-tocopherol and annatto 
T3s (gamma and delta T3).  Overall, the main organs that accumulated alpha-tocopherol, 
gamma-T3, and delta-T3 were the fat pad, liver and gall bladder, oviduct, forming yolks, 
laid yolks, kidney, brain, thigh, and breast.  Same as seen in the previous study (Hansen 
et al., 2014), much more of alpha-tocopherol is transferred into the hen’s body from the 
feed than the annatto T3s.  Alpha-tocopherol only significantly decreased the transfer of 
gamma-T3 to the laid and forming eggs, but this trend was not seen in delta-T3.   
Cholesterol content was not significantly impacted in most tissues (breast, thigh, liver and 
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gall bladder, kidney, and oviduct) except the heart.  When determining how a nutrient is 
distributed in a biological system, such as a laying-hen, it is important to consider what 
the function(s) that the nutrient has for each unique organ or tissue.     
This study illustrated that by changing nutrient composition of laying-hen feed it 
is possible to produce a more nutritious egg that and alter to the distribution of alpha-
tocopherol, gamma-T3, and delta-T3in various organs and tissues.  Increasing these 
nutrients in a biological system may have benefits to the health of the laying-hen and 
stability of the meat products, although minimal impacts to cholesterol content in the 
eggs and various organs were seen.  With much of the annatto T3s being excreted a more 
efficient delivery system is needed to overcome the bio discrimination for alpha-
tocopherol.  Supplementing chicken feed with vitamin E may have future applications in 
the broiler industry with increased feed intake that could lead to faster weight gain and 
increased oxidative stability with more vitamin E present in the laying-hen.   
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Appendix  
 
Table 1.  Yolk Moisture and Oil Contents for Diets with Different Levels of Annatto 
(T3) and Alpha-Tocopherol (TC) Supplementation (n=4) 
a 
 
 
Diets 
 
Yolk Moisture (%) 
 
 
Yolk Oil (%, db) 
Control 48.30 ± 0.21  63.96 ± 1.25  
T3 100 48.34 ± 1.01  64.34 ± 1.23  
T3 500 48.50 ± 0.27  63.88 ± 1.48  
T3 2000 48.42 ± 0.62  64.30 ± 0.43 
TC 200 48.76 ± 0.23  63.68 ± 0.87  
TC 600 48.50 ± 0.15  64.00 ± 0.44 
TC 1000 48.84 ± 0.34  63.43 ± 0.53 
Significance 
c
 NS NS 
a 
Values are means ± standard deviations. 
b 
Diets in Table 2 above, T3=Annatto, TC=alpha-
tocopherol. Different letters in the same column indicate significant differences at the 95% 
confidence level. 
C
 p-value= 0.05, NS not significant at 5%.   
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Table 2. Phospholipid Composition of Egg Yolk Oil Determined by 
31
P NMR for diets with Different Levels of 
Annatto (T3) and Alpha-Tocopherol (TC) Supplementation (n=4) 
a
 
 
 
Diets 
 
PC  
(Wt. %) 
 
 
PI 
 (Wt. %) 
 
LPC  
(Wt. %) 
 
SM 
 (Wt. %) 
 
PE  
(Wt. %) 
 
LPE  
(Wt. %) 
 
Total PLs 
(Wt. %) 
Control 75.40 ± 0.90 0.82 ± 0.56 1.36 ± 0.31 2.17 ± 0.33 19.45 ± 0.51 0.80 ± 0.10 24.94 ± 5.58 
T3 100 75.41 ± 0.71 1.42 ± 0.44 1.35 ± 0.24 2.12 ± 0.24 19.00 ± 0.91 0.70 ± 0.22 23.71 ± 4.80 
T3 500 75.54 ± 0.66 1.04 ± 0.21 1.30 ± 0.065 2.31 ± 0.35 19.05 ± 0.53 0.75 ± 0.050 23.20 ± 6.33 
T3 2000 74.93 ± 1.20 1.00 ± 0.076 1.22 ± 0.29 1.90 ± 0.39 20.25 ± 1.03 0.70 ± 0.23 24.03 ± 4.94 
TC 200 75.46 ± 1.08 1.17 ± 0.59 1.35 ± 0.12 2.03 ± 0.38 19.19 ± 0.50 0.79 ± 0.19 21.11 ± 6.02 
TC 600 74.79 ± 1.77 1.48 ± 0.58 1.43 ± 0.10 2.47 ± 0.29 19.17 ± 1.5 0.66 ± 0.15 22.31 ± 3.78 
TC 1000 74.74 ± 1.48 1.41 ± 0.61 1.44 ± 0.18 1.90 ± 0.37 20.18 ± 1.12 0.59 ± 0.093 22.19 ± 3.39 
Significance NS NS NS NS NS NS NS 
a 
Values are means ± standard deviations. 
b 
Diets in Table 2 above, T3=Annatto, TC=alpha-tocopherol. Different letters 
in the same column indicate significant differences at the 95% confidence level. 
C
 * p-value= 0.05, NS not significant at 
5%.   
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Table 3. Fatty Acid Composition for Egg Yolks from Diets with Different Levels of Annatto (T3) and Alpha-
Tocopherol (TC) Supplementation (n=4) 
a
 
 
 
Diets
 b
 
16:0  
(%) 
 
16:1 
 (%) 
 
18:0  
(%) 
 
18:1 
 (%) 
 
18:2  
(%) 
 
20:4  
(%) 
 
 
22:6  
(%) 
 
Control 26.26 ± 0.72 2.57 ± 0.09  9.47 ± 0.22 40.92 ± 4.15 16.46 ± 0.20 2.09 ± 0.08 0.53 ± 0.01 
T3 100 25.03 ± 0.81 2.47 ± 0.11  9.29 ± 0.78 39.59 ± 1.25 17.05 ± 0.95 1.88 ± 0.38 0.48 ± 0.10 
T3 500 24.67 ± 0.28 2.15 ± 0.23  9.78 ± 0.64 40.15 ± 0.79 16.90 ± 0.43 1.99 ± 0.24 0.48 ± 0.19 
T3 2000 25.43 ± 0.40 2.29 ± 0.12  10.05 ± 0.22 39.53 ± 0.95 16.14 ± 0.48 2.10 ± 0.08 0.57 ± 0.04 
TC 200 25.06 ± 1.36 2.35 ± 0.37  9.51 ± 0.11 40.01 ± 1.11 16.48 ± 0.66 2.10 ± 0.11 0.57 ± 0.03 
TC 600 24.37 ± 0.92 2.04 ± 0.10  9.97 ± 0.74 40.23 ± 1.18 16.60 ± 0.59 2.19 ± 0.11 0.60 ± 0.04 
TC 1000 24.77 ± 0.66 2.19 ± 0.19  9.92 ± 0.30 40.44 ± 0.41 15.91 ± 032 2.17 ± 0.19 0.58 ± 0.06 
Significance 
c
 NS NS NS NS NS NS NS 
a 
Values are means ± standard deviations. 
b 
Diets in Table 2 above, T3=Annatto, TC=alpha-tocopherol. Different letters in 
the same column indicate significant differences at the 99% confidence level. 
C
 *p-value= 0.01, NS not significant at 1%.  
 
 
 
 
 
 
 
